# EDGAR Filing Document

**Accession Number:** 0000077476
**File Stem:** 0000077476-25-000053
**Filing Date:** 2025-10
**Character Count:** 206365
**Document Hash:** b009e627c930951e56c9b59d61338ba2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000077476-25-000053.hdr.sgml**: 20251009

**ACCESSION NUMBER**: 0000077476-25-000053

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 92

**CONFORMED PERIOD OF REPORT**: 20250906

**FILED AS OF DATE**: 20251009

**DATE AS OF CHANGE**: 20251008

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PEPSICO INC
- **CENTRAL INDEX KEY:** 0000077476
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 131584302
- **STATE OF INCORPORATION:** NC
- **FISCAL YEAR END:** 1227

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-01183
- **FILM NUMBER:** 251383367

**BUSINESS ADDRESS:**
- **STREET 1:** 700 ANDERSON HILL RD
- **CITY:** PURCHASE
- **STATE:** NY
- **ZIP:** 10577
- **BUSINESS PHONE:** 9142532000

**MAIL ADDRESS:**
- **STREET 1:** 700 ANDERSON HILL ROAD
- **CITY:** PURCHASE
- **STATE:** NY
- **ZIP:** 10577-1444

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PEPSI COLA CO
- **DATE OF NAME CHANGE:** 19700903

?xml version='1.0' encoding='ASCII'? pep-20250906

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q** 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 6, 2025 (36 weeks)

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Commission file number <u>1-1183</u>![PepsiCo12-alt-300.jpg](pep-20250906_g1.jpg)

<u>PepsiCo, Inc.</u>

(Exact Name of Registrant as Specified in its Charter)

---

| | |
|:---|:---|
| <u>North Carolina</u> | <u>13-1584302</u> |
| (State or Other Jurisdiction of<br>Incorporation or Organization) | (I.R.S. Employer<br>Identification No.) |

---

700 Anderson Hill Road, Purchase, New York 10577

(Address of principal executive offices and Zip Code)

(914) 253-2000

Registrant's telephone number, including area code

N/A

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbols** | **Name of each exchange on which registered** |
| Common Stock, par value 1-2/3 cents per share | PEP | The Nasdaq Stock Market LLC |
| 2.625% Senior Notes Due 2026 | PEP26 | The Nasdaq Stock Market LLC |
| 0.750% Senior Notes Due 2027 | PEP27 | The Nasdaq Stock Market LLC |
| 0.875% Senior Notes Due 2028 | PEP28 | The Nasdaq Stock Market LLC |
| 0.500% Senior Notes Due 2028 | PEP28A | The Nasdaq Stock Market LLC |
| 3.200% Senior Notes Due 2029 | PEP29 | The Nasdaq Stock Market LLC |
| 1.125% Senior Notes Due 2031 | PEP31 | The Nasdaq Stock Market LLC |
| 0.400% Senior Notes Due 2032 | PEP32 | The Nasdaq Stock Market LLC |
| 0.750% Senior Notes Due 2033 | PEP33 | The Nasdaq Stock Market LLC |
| 3.550% Senior Notes Due 2034 | PEP34 | The Nasdaq Stock Market LLC |
| 3.450% Senior Notes Due 2037 | PEP37 | The Nasdaq Stock Market LLC |
| 0.875% Senior Notes Due 2039 | PEP39 | The Nasdaq Stock Market LLC |
| 1.050% Senior Notes Due 2050 | PEP50 | The Nasdaq Stock Market LLC |
| 4.050% Senior Notes Due 2055 | PEP55 | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻&nbsp;&nbsp;&nbsp;&nbsp;

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes **☐**&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Number of shares of Common Stock outstanding as of October 2, 2025 was 1,367,340,122.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**PepsiCo, Inc. and Subsidiaries**

**Table of Contents**

---

| | | |
|:---|:---|:---|
| | | <u>Page No.</u> |
| Part I Financial Information | Part I Financial Information | |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 1. | Condensed Consolidated Financial Statements | <u>[2](#i24b2960c8bf94fd09c758d4af3964e6e_13)</u> |
| | <u>[Condensed Consolidated Statement of Income –](#i24b2960c8bf94fd09c758d4af3964e6e_16)</u> <u>[12 and](#i24b2960c8bf94fd09c758d4af3964e6e_16)[3](#i24b2960c8bf94fd09c758d4af3964e6e_16)[6](#i24b2960c8bf94fd09c758d4af3964e6e_16)[Weeks Ended](#i24b2960c8bf94fd09c758d4af3964e6e_16)[September 6, 2025](#i24b2960c8bf94fd09c758d4af3964e6e_16)[and September 7, 2024](#i24b2960c8bf94fd09c758d4af3964e6e_22)</u> | <u>[2](#i24b2960c8bf94fd09c758d4af3964e6e_16)</u> |
| | <u>[Condensed Consolidated Statement of Comprehensive Income –](#i24b2960c8bf94fd09c758d4af3964e6e_19)</u> <u>[12 and](#i24b2960c8bf94fd09c758d4af3964e6e_16)[36](#i24b2960c8bf94fd09c758d4af3964e6e_16)[Weeks Ended](#i24b2960c8bf94fd09c758d4af3964e6e_19)[September 6, 2025](#i24b2960c8bf94fd09c758d4af3964e6e_16)[and September 7, 2024](#i24b2960c8bf94fd09c758d4af3964e6e_22)</u> | <u>[3](#i24b2960c8bf94fd09c758d4af3964e6e_19)</u> |
| | <u>[Condensed Consolidated Statement of Cash Flows –](#i24b2960c8bf94fd09c758d4af3964e6e_22)</u> <u>[36](#i24b2960c8bf94fd09c758d4af3964e6e_16)[Weeks Ended](#i24b2960c8bf94fd09c758d4af3964e6e_22)[September 6, 2025](#i24b2960c8bf94fd09c758d4af3964e6e_16)[and](#i24b2960c8bf94fd09c758d4af3964e6e_22)[September](#i24b2960c8bf94fd09c758d4af3964e6e_22)[7](#i24b2960c8bf94fd09c758d4af3964e6e_22)[, 2024](#i24b2960c8bf94fd09c758d4af3964e6e_22)</u> | <u>[4](#i24b2960c8bf94fd09c758d4af3964e6e_22)</u> |
| | <u>[Condensed Consolidated Balance Sheet –](#i24b2960c8bf94fd09c758d4af3964e6e_25)</u> <u>[September 6, 2025](#i24b2960c8bf94fd09c758d4af3964e6e_16)[and December 28, 2024](#i24b2960c8bf94fd09c758d4af3964e6e_25)</u> | <u>[6](#i24b2960c8bf94fd09c758d4af3964e6e_25)</u> |
| | <u>[Condensed Consolidated Statement of Equity –](#i24b2960c8bf94fd09c758d4af3964e6e_31)</u> <u>[12 and](#i24b2960c8bf94fd09c758d4af3964e6e_16)[36](#i24b2960c8bf94fd09c758d4af3964e6e_16)[Weeks Ended](#i24b2960c8bf94fd09c758d4af3964e6e_31)[September 6, 2025](#i24b2960c8bf94fd09c758d4af3964e6e_16)[and September 7, 2024](#i24b2960c8bf94fd09c758d4af3964e6e_22)</u> | <u>[7](#i24b2960c8bf94fd09c758d4af3964e6e_31)</u> |
| | <u>[Notes to the Condensed Consolidated Financial Statements](#i24b2960c8bf94fd09c758d4af3964e6e_37)</u> | <u>[8](#i24b2960c8bf94fd09c758d4af3964e6e_37)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i24b2960c8bf94fd09c758d4af3964e6e_142)</u> | <u>[31](#i24b2960c8bf94fd09c758d4af3964e6e_142)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Report of Independent Registered Public Accounting Firm | &nbsp;&nbsp;&nbsp;&nbsp;Report of Independent Registered Public Accounting Firm | <u>[51](#i24b2960c8bf94fd09c758d4af3964e6e_253)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 3. | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i24b2960c8bf94fd09c758d4af3964e6e_256)</u> | <u>[52](#i24b2960c8bf94fd09c758d4af3964e6e_256)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 4. | <u>[Controls and Procedures](#i24b2960c8bf94fd09c758d4af3964e6e_259)</u> | <u>[52](#i24b2960c8bf94fd09c758d4af3964e6e_259)</u> |
| Part II Other Information | Part II Other Information | |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 1. | <u>[Legal Proceedings](#i24b2960c8bf94fd09c758d4af3964e6e_265)</u> | <u>[53](#i24b2960c8bf94fd09c758d4af3964e6e_265)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 1A. | <u>[Risk Factors](#i24b2960c8bf94fd09c758d4af3964e6e_268)</u> | <u>[53](#i24b2960c8bf94fd09c758d4af3964e6e_268)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 2. | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i24b2960c8bf94fd09c758d4af3964e6e_271)</u> | <u>[54](#i24b2960c8bf94fd09c758d4af3964e6e_271)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 5. | <u>[Other Information](#i24b2960c8bf94fd09c758d4af3964e6e_274)</u> | <u>[54](#i24b2960c8bf94fd09c758d4af3964e6e_274)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 6. | <u>[Exhibits](#i24b2960c8bf94fd09c758d4af3964e6e_277)</u> | <u>[54](#i24b2960c8bf94fd09c758d4af3964e6e_277)</u> |

---

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**PART I FINANCIAL INFORMATION**

**ITEM 1. Condensed Consolidated Financial Statements.**

**Condensed Consolidated Statement of Income**

PepsiCo, Inc. and Subsidiaries

(in millions, except per share amounts, unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| **Net Revenue** | $**23937** | $23319 | $**64582** | $64070 |
| Cost of sales | **11113** | 10396 | **29343** | 28563 |
| Gross profit | **12824** | 12923 | **35239** | 35507 |
| Selling, general and administrative expenses | **9122** | 9027 | **25305** | 24846 |
| Impairment of intangible assets (see Notes 1 and 4) | **133** | 24 | **1993** | 24 |
| **Operating Profit** | **3569** | 3872 | **7941** | 10637 |
| Other pension and retiree medical benefits income | **26** | 41 | **91** | 155 |
| Net interest expense and other | **(264)** | (219) | **(788)** | (655) |
| Income before income taxes | **3331** | 3694 | **7244** | 10137 |
| Provision for income taxes | **713** | 749 | **1504** | 2045 |
| Net income | **2618** | 2945 | **5740** | 8092 |
| Less: Net income attributable to noncontrolling interests | **15** | 15 | **40** | 37 |
| **Net Income Attributable to PepsiCo** | $**2603** | $2930 | $**5700** | $8055 |
| **Net Income Attributable to PepsiCo per Common Share** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Basic** | $**1.90** | $2.13 | $**4.16** | 5.86 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Diluted** | $**1.90** | $2.13 | $**4.15** | 5.84 |
| Weighted-average common shares outstanding |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | **1369** | 1373 | **1370** | 1374 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | **1372** | 1378 | **1373** | 1379 |

---

See accompanying notes to the condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Condensed Consolidated Statement of Comprehensive Income**

PepsiCo, Inc. and Subsidiaries

(in millions, unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Net income | $**2618** | $2945 | $**5740** | $8092 |
| Other comprehensive income/(loss), net of taxes: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net currency translation adjustment | **39** | (512) | **1436** | (961) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change on cash flow hedges | **23** | (24) | **27** | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net pension and retiree medical adjustments | **21** | 21 | **12** | 41 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change on available-for-sale debt securities and other | **410** | (351) | **540** | (219) |
| Total other comprehensive income/(loss), net of taxes | **493** | (866) | **2015** | (1118) |
| Comprehensive income | **3111** | 2079 | **7755** | 6974 |
| &nbsp;&nbsp;&nbsp;Less: Comprehensive income attributable to<br>noncontrolling interests | **15** | 15 | **40** | 37 |
| **Comprehensive Income Attributable to PepsiCo** | $**3096** | $2064 | $**7715** | $6937 |

---

See accompanying notes to the condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Condensed Consolidated Statement of Cash Flows**

PepsiCo, Inc. and Subsidiaries

(in millions, unaudited)

---

| | | |
|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 |
| **Operating Activities** |  |  |
| Net income | $**5740** | $8092 |
| Depreciation and amortization | **2315** | 2118 |
| Impairment and other charges | **1960** | 10 |
| Product recall-related impact | **—** | 184 |
| Cash payments for product recall-related impact | **(5)** | (138) |
| Operating lease right-of-use asset amortization | **489** | 438 |
| Share-based compensation expense | **207** | 260 |
| Restructuring and impairment charges | **567** | 415 |
| Cash payments for restructuring charges | **(554)** | (284) |
| Acquisition and divestiture-related charges | **308** | 7 |
| Cash payments for acquisition and divestiture-related charges | **(80)** | (4) |
| Pension and retiree medical plan expenses | **164** | 114 |
| Pension and retiree medical plan contributions | **(400)** | (300) |
| Deferred income taxes and other tax charges and credits | **30** | 124 |
| Tax payments related to the Tax Cuts and Jobs Act (TCJ Act) | **(772)** | (579) |
| Change in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable | **(1747)** | (1521) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | **(449)** | (492) |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **(223)** | (200) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other current liabilities | **(1647)** | (2312) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | **6** | 426 |
| Other, net | **(441)** | (138) |
| **Net Cash Provided by Operating Activities** | **5468** | 6220 |
| **Investing Activities** |  |  |
| Capital spending | **(2499)** | (2850) |
| Sales of property, plant and equipment | **272** | 177 |
| Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | **(3176)** | (31) |
| Divestitures, sales of investments in noncontrolled affiliates and other assets | **5** | 145 |
| Short-term investments, by original maturity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;More than three months - purchases | **(190)** | (425) |
| &nbsp;&nbsp;&nbsp;&nbsp;More than three months - maturities | **425** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Three months or less, net | **43** | 4 |
| Other investing, net | **(117)** | 15 |
| **Net Cash Used for Investing Activities** | **(5237)** | (2965) |

---

&nbsp;&nbsp;&nbsp;&nbsp;

(Continued on following page)

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Condensed Consolidated Statement of Cash Flows (continued)**

PepsiCo, Inc. and Subsidiaries

(in millions, unaudited)

---

| | | |
|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 |
| **Financing Activities** |  |  |
| Proceeds from issuances of long-term debt | $**8179** | $4014 |
| Payments of long-term debt | **(3245)** | (2883) |
| Short-term borrowings, by original maturity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;More than three months - proceeds | **5528** | 3808 |
| &nbsp;&nbsp;&nbsp;&nbsp;More than three months - payments | **(5417)** | (4177) |
| &nbsp;&nbsp;&nbsp;&nbsp;Three months or less, net | **445** | 101 |
| Cash dividends paid | **(5692)** | (5369) |
| Share repurchases | **(752)** | (760) |
| Proceeds from exercises of stock options | **76** | 138 |
| Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | **(112)** | (132) |
| Other financing | **(18)** | (22) |
| **Net Cash Used for Financing Activities** | **(1008)** | (5282) |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | **395** | (391) |
| **Net Decrease in Cash and Cash Equivalents and Restricted Cash** | **(382)** | (2418) |
| **Cash and Cash Equivalents and Restricted Cash, Beginning of Year** | **8553** | 9761 |
| **Cash and Cash Equivalents and Restricted Cash, End of Period** | $**8171** | $7343 |
| **Supplemental Non-Cash Activity** |  |  |
| Right-of-use assets obtained in exchange for lease obligations | $**542** | $869 |
| Investment obtained for certain assets (see Notes 4 and 9) | $**554** | $— |

---

See accompanying notes to the condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Condensed Consolidated Balance Sheet**

PepsiCo, Inc. and Subsidiaries

(in millions, except per share amounts)

---

| | | |
|:---|:---|:---|
| | **(Unaudited)**<br>**9/6/2025** |<br>12/28/2024 |
| **ASSETS** |  |  |
| **Current Assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**8126** | $8505 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments | **535** | 761 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable, less allowance ($245 and $356, respectively) | **12634** | 10333 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Raw materials and packaging | **2805** | 2440 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Work-in-process | **154** | 104 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finished goods | **3134** | 2762 |
|  | **6093** | 5306 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **1334** | 921 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Current Assets** | **28722** | 25826 |
| Property, plant and equipment | **59309** | 56005 |
| Accumulated depreciation | **(30256)** | (27997) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Property, Plant and Equipment, net** | **29053** | 28008 |
| **Amortizable Intangible Assets, net** | **1241** | 1102 |
| **Goodwill** | **18845** | 17534 |
| **Other Indefinite-Lived Intangible Assets** | **13611** | 13699 |
| **Investments in Noncontrolled Affiliates** | **2084** | 1985 |
| **Deferred Income Taxes** | **4341** | 4362 |
| **Other Assets** | **8661** | 6951 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Assets** | $**106558** | $99467 |
| **LIABILITIES AND EQUITY** |  |  |
| **Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Short-term debt obligations | $**6736** | $7082 |
| &nbsp;&nbsp;&nbsp;Accounts payable and other current liabilities | **24763** | 24454 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Current Liabilities** | **31499** | 31536 |
| **Long-Term Debt Obligations** | **44113** | 37224 |
| **Deferred Income Taxes** | **3474** | 3484 |
| **Other Liabilities** | **7929** | 9052 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Liabilities** | **87015** | 81296 |
| Commitments and contingencies |  |  |
| **PepsiCo Common Shareholders' Equity** |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, par value 1<sup>2</sup>/3¢ per share (authorized 3,600 shares; issued, net of repurchased common stock at par value: 1,369 and 1,372 shares, respectively) | **23** | 23 |
| &nbsp;&nbsp;&nbsp;Capital in excess of par value | **4374** | 4385 |
| &nbsp;&nbsp;&nbsp;Retained earnings | **72197** | 72266 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(15597)** | (17612) |
| &nbsp;&nbsp;&nbsp;Repurchased common stock, in excess of par value (498 and 495 shares, respectively) | **(41609)** | (41021) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total PepsiCo Common Shareholders' Equity** | **19388** | 18041 |
| Noncontrolling interests | **155** | 130 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Equity** | **19543** | 18171 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Liabilities and Equity** | $**106558** | $99467 |

---

See accompanying notes to the condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Condensed Consolidated Statement of Equity**

PepsiCo, Inc. and Subsidiaries

(in millions, except per share amounts, unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | **9/6/2025** | 9/7/2024 | 9/7/2024 | **9/6/2025** | **9/6/2025** | 9/7/2024 | 9/7/2024 |
| | **Shares** | **Amount** | Shares | Amount | **Shares** | **Amount** | Shares | Amount |
| **Common Stock** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period | **1371** | $**23** | 1374 | $23 | **1372** | $**23** | 1374 | $23 |
| &nbsp;&nbsp;&nbsp;Change in repurchased common stock | **(2)** | **—** | (1) |  | **(3)** | **—** | (1) |  |
| &nbsp;&nbsp;&nbsp;Balance, end of period | **1369** | **23** | 1373 | 23 | **1369** | **23** | 1373 | 23 |
| **Capital in Excess of Par Value** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period |  | **4299** |  | 4203 |  | **4385** |  | 4261 |
| &nbsp;&nbsp;&nbsp;Share-based compensation expense |  | **75** |  | 76 |  | **204** |  | 255 |
| &nbsp;&nbsp;&nbsp;Stock option exercises, RSUs and PSUs converted |  | **4** |  | 9 |  | **(96)** |  | (95) |
| &nbsp;&nbsp;&nbsp;Withholding tax on RSUs and PSUs converted |  | **(1)** |  | (1) |  | **(112)** |  | (132) |
| &nbsp;&nbsp;&nbsp;Other |  | **(3)** |  | (6) |  | **(7)** |  | (8) |
| &nbsp;&nbsp;&nbsp;Balance, end of period |  | **4374** |  | 4281 |  | **4374** |  | 4281 |
| **Retained Earnings** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period |  | **71547** |  | 71545 |  | **72266** |  | 70035 |
| &nbsp;&nbsp;&nbsp;Net income attributable to PepsiCo |  | **2603** |  | 2930 |  | **5700** |  | 8055 |
| &nbsp;&nbsp;&nbsp;Cash dividends declared <sup>(a)</sup> |  | **(1953)** |  | (1868) |  | **(5769)** |  | (5483) |
| &nbsp;&nbsp;&nbsp;Balance, end of period |  | **72197** |  | 72607 |  | **72197** |  | 72607 |
| **Accumulated Other Comprehensive Loss** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period |  | **(16090)** |  | (15786) |  | **(17612)** |  | (15534) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income/(loss) attributable to PepsiCo |  | **493** |  | (866) |  | **2015** |  | (1118) |
| &nbsp;&nbsp;&nbsp;Balance, end of period |  | **(15597)** |  | (16652) |  | **(15597)** |  | (16652) |
| **Repurchased Common Stock** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period | **(496)** | **(41361)** | (493) | (40539) | **(495)** | **(41021)** | (493) | (40282) |
| &nbsp;&nbsp;&nbsp;Share repurchases | **(2)** | **(263)** | (2) | (294) | **(5)** | **(760)** | (5) | (762) |
| &nbsp;&nbsp;&nbsp;Stock option exercises, RSUs and PSUs converted | **—** | **15** | 1 | 23 | **2** | **172** | 4 | 233 |
| &nbsp;&nbsp;&nbsp;Other | **—** | **—** |  | 4 | **—** | **—** |  | 5 |
| &nbsp;&nbsp;&nbsp;Balance, end of period | **(498)** | **(41609)** | (494) | (40806) | **(498)** | **(41609)** | (494) | (40806) |
| **Total PepsiCo Common Shareholders' Equity** |  | **19388** |  | 19453 |  | **19388** |  | 19453 |
| **Noncontrolling Interests** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period |  | **141** |  | 134 |  | **130** |  | 134 |
| &nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests |  | **15** |  | 15 |  | **40** |  | 37 |
| &nbsp;&nbsp;&nbsp;Distributions to noncontrolling interests |  | **—** |  |  |  | **(15)** |  | (17) |
| &nbsp;&nbsp;&nbsp;Other, net |  | **(1)** |  | 3 |  | **—** |  | (2) |
| &nbsp;&nbsp;&nbsp;Balance, end of period |  | **155** |  | 152 |  | **155** |  | 152 |
| **Total Equity** |  | $**19543** |  | $19605 |  | $**19543** |  | $19605 |

---

(a)Cash dividends declared per common share were $1.4225 and $1.3550 for the 12 weeks ended September 6, 2025 and September 7, 2024, respectively, and $4.2000 and $3.9750 for the 36 weeks ended September 6, 2025 and September 7, 2024, respectively.

See accompanying notes to the condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Notes to the Condensed Consolidated Financial Statements**

**Note 1 - Basis of Presentation and Our Segments**

***Basis of Presentation***

When used in this report, the terms "we," "us," "our," "PepsiCo" and the "Company" mean PepsiCo, Inc. and its consolidated subsidiaries, collectively.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) for interim financial information and with the rules and regulations for reporting the Quarterly Report on Form 10-Q (Form 10-Q). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. We have subsidiaries operating in highly inflationary economies, such as Argentina, Egypt and Turkey, and accordingly apply highly inflationary accounting for these subsidiaries. The condensed consolidated balance sheet at December 28, 2024 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in our Annual Report on Form 10-K for the fiscal year ended December 28, 2024 (2024 Form 10-K) and in Exhibit 99.2 to our Current Report on Form 8-K dated July 17, 2025 (Recast Segment Information). This report should be read in conjunction with our 2024 Form 10-K and our Recast Segment Information, in which we retrospectively recast historical segment reporting to reflect our current organizational structure. In our opinion, these financial statements include all normal and recurring adjustments necessary for a fair presentation. The results for the 12 and 36 weeks ended September 6, 2025 are not necessarily indicative of the results expected for any future period or the full year.

Raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw materials handling facilities, are included in cost of sales. The costs of moving, storing and delivering finished product, including merchandising activities, are included in selling, general and administrative expenses.

While our financial results in the United States and Canada (North America) are reported on a 12-week basis, all of our international operations are reported on a monthly calendar basis for which the months of June, July and August are reflected in our results for the 12 weeks ended September 6, 2025 and September 7, 2024, and the months of January through August are reflected in our results for the 36 weeks ended September 6, 2025 and September 7, 2024.

The preparation of our condensed consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and related disclosures. Additionally, the business and economic uncertainty resulting from volatile geopolitical conditions, an increasingly complex global tax environment, including changes in how existing laws are interpreted or enforced, expanded or retaliatory tariffs and changes in the interest rate and inflationary cost environment have made such estimates and assumptions more difficult to calculate. Accordingly, actual results and outcomes could differ from those estimates.

Our significant interim accounting policies include the recognition of a pro rata share of certain estimated annual sales incentives and certain advertising and marketing costs in proportion to revenue or volume, as applicable, and the recognition of income taxes using an estimated annual effective tax rate.

Unless otherwise noted, tabular dollars are in millions, except per share amounts. All per share amounts reflect common per share amounts, assume dilution unless otherwise noted, and are based on unrounded amounts. Certain reclassifications were made to the prior year's financial statements to conform to the current year presentation.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

***Our Segments***

As previously disclosed in our 2024 Form 10-K, effective beginning with our first quarter of 2025, we realigned certain of our reportable segments to conform with changes to our organizational structure and how our Chief Executive Officer regularly reviews the performance of, and allocates resources to, these segments. Our historical segment reporting has been recast to reflect our current organizational structure.

We are organized into six reportable segments, as follows:

1)PepsiCo Foods North America (PFNA), which includes all of our convenient food businesses in the United States and Canada;

2)PepsiCo Beverages North America (PBNA), which includes all of our beverage businesses in the United States and Canada;

3)International Beverages Franchise (IB Franchise), which includes our international franchise beverage businesses, as well as our SodaStream business;

4)Europe, Middle East and Africa (EMEA), which includes our convenient food businesses and beverage businesses with company-owned bottlers in Europe, the Middle East and Africa;

5)Latin America Foods (LatAm Foods), which includes all of our convenient food businesses in Latin America; and

6)Asia Pacific Foods, which consists of our convenient food businesses in Asia Pacific, including China, Australia and New Zealand, as well as India.

***Net Revenue, Significant Expenses and Operating Profit by Segment***

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** |
| | **PFNA** | **PBNA** | **IB Franchise** | **EMEA** | **LatAm Foods** | **Asia Pacific Foods** | **Total** |
| Net revenue | $6526 | $7327 | $1291 | $5022 | $2656 | $1115 | $23937 |
| Segment cost of sales <sup>(a)</sup> | 2557 | 3407 | 405 | 2864 | 1134 | 666 |  |
| Segment selling, general and administrative expenses <sup>(a)</sup> | 2399 | 2945 | 375 | 1350 | 999 | 293 |  |
| Restructuring and impairment charges <sup>(b)</sup> | 32 | 19 | 2 | 69 | 17 | 5 |  |
| Acquisition and divestiture-related charges <sup>(c)</sup> | 2 | 219 |  |  |  |  |  |
| Impairment and other charges <sup>(d)</sup> |  | 8 | 73 | 19 |  |  |  |
| Indirect and income tax impact <sup>(e)</sup> |  |  |  |  | 82 |  |  |
| Segment operating profit | $1536 | $729 | $436 | $720 | $424 | $151 | $3996 |
| Corporate unallocated expenses |  |  |  |  |  |  | (427) |
| Operating profit |  |  |  |  |  |  | 3569 |
| Other pension and retiree medical benefits income |  |  |  |  |  |  | 26 |
| Net interest expense and other |  |  |  |  |  |  | (264) |
| Income before income taxes |  |  |  |  |  |  | $3331 |

---

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 |
| | PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Total |
| Net revenue | $6536 | $7175 | $1290 | $4612 | $2615 | $1091 | $23319 |
| Segment cost of sales <sup>(a)</sup> | 2489 | 3188 | 386 | 2578 | 1092 | 635 |  |
| Segment selling, general and administrative expenses <sup>(a)</sup> | 2420 | 2940 | 431 | 1276 | 1032 | 325 |  |
| Restructuring and impairment charges <sup>(b)</sup> | 8 | 128 | 15 | 35 | 11 | 2 |  |
| Acquisition and divestiture-related charges <sup>(c)</sup> |  | 5 |  |  |  |  |  |
| Impairment and other charges |  |  |  | 10 |  |  |  |
| Product recall-related impact | (1) |  |  |  |  |  |  |
| Segment operating profit | $1620 | $914 | $458 | $713 | $480 | $129 | $4314 |
| Corporate unallocated expenses |  |  |  |  |  |  | (442) |
| Operating profit |  |  |  |  |  |  | 3872 |
| Other pension and retiree medical benefits income |  |  |  |  |  |  | 41 |
| Net interest expense and other |  |  |  |  |  |  | (219) |
| Income before income taxes |  |  |  |  |  |  | $3694 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** |
| | **PFNA** | **PBNA** | **IB Franchise** | **EMEA** | **LatAm Foods** | **Asia Pacific Foods** | **Total** |
| Net revenue | $19215 | $19999 | $3418 | $11946 | $6865 | $3139 | $64582 |
| Segment cost of sales <sup>(a)</sup> | 7376 | 9056 | 1017 | 6909 | 2906 | 1905 |  |
| Segment selling, general and administrative expenses <sup>(a)</sup> | 7206 | 8379 | 1073 | 3339 | 2540 | 824 |  |
| Restructuring and impairment charges <sup>(b)</sup> | 147 | 192 | 7 | 118 | 36 | 9 |  |
| Acquisition and divestiture-related charges <sup>(c)</sup> | 23 | 285 |  |  |  |  |  |
| Impairment and other charges <sup>(d)</sup> |  | 1537 | 73 | 270 |  | 80 |  |
| Indirect and income tax impact <sup>(e)</sup> |  |  |  |  | 82 |  |  |
| Segment operating profit | $4463 | $550 | $1248 | $1310 | $1301 | $321 | $9193 |
| Corporate unallocated expenses |  |  |  |  |  |  | (1252) |
| Operating profit |  |  |  |  |  |  | 7941 |
| Other pension and retiree medical benefits income |  |  |  |  |  |  | 91 |
| Net interest expense and other |  |  |  |  |  |  | (788) |
| Income before income taxes |  |  |  |  |  |  | $7244 |

---

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 |
| | PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Total |
| Net revenue | $19240 | $19860 | $3355 | $11228 | $7254 | $3133 | $64070 |
| Segment cost of sales <sup>(a)</sup> | 7091 | 8993 | 1003 | 6455 | 3002 | 1842 |  |
| Segment selling, general and administrative expenses <sup>(a)</sup> | 7119 | 8306 | 1116 | 3179 | 2784 | 878 |  |
| Restructuring and impairment charges <sup>(b)</sup> | 47 | 143 | 15 | 75 | 32 | 6 |  |
| Acquisition and divestiture-related charges <sup>(c)</sup> |  | 7 |  |  |  |  |  |
| Impairment and other charges |  |  |  | 10 |  |  |  |
| Product recall-related impact <sup>(f)</sup> | 181 |  |  |  |  |  |  |
| Segment operating profit | $4802 | $2411 | $1221 | $1509 | $1436 | $407 | $11786 |
| Corporate unallocated expenses <sup>(g)</sup> |  |  |  |  |  |  | (1149) |
| Operating profit |  |  |  |  |  |  | 10637 |
| Other pension and retiree medical benefits income |  |  |  |  |  |  | 155 |
| Net interest expense and other |  |  |  |  |  |  | (655) |
| Income before income taxes |  |  |  |  |  |  | $10137 |

---

(a)Does not include items recorded in the cost of sales or selling, general and administrative expenses lines on our income statement that are presented in the restructuring and impairment charges, acquisition and divestiture-related charges, impairment and other charges, indirect and income tax impact and product recall-related impact lines of these tables.

(b)See Note 3 for further information related to restructuring and impairment charges.

(c)See Note 12 for further information related to acquisitions and divestiture-related charges.

(d)In the 12 weeks ended September 6, 2025, we recorded pre-tax charges of $100 million ($92 million after tax or $0.07 per share), primarily related to the impairment of the Rockstar brand in our IB Franchise and PBNA segments, with $83 million recorded in impairment of intangible assets and $17 million recorded in selling, general and administrative expenses. In the 36 weeks ended September 6, 2025, we recorded pre-tax charges of $1,960 million ($1,539 million after-tax or $1.12 per share), primarily related to the impairment of the Rockstar brand in our PBNA, EMEA and IB Franchise segments and the Be & Cheery brand in our Asia Pacific Foods segment, with $1,943 million recorded in impairment of intangible assets and $17 million recorded in selling, general and administrative expenses. See Note 4 for further information.

(e)In the 12 and 36 weeks ended September 6, 2025, we recorded a pre-tax charge of $82 million in selling, general and administrative expenses and income tax expense of $47 million in provision for income taxes (collectively, $0.09 per share) related to an indirect and income tax audit settlement in our LatAm Foods segment.

(f)In the 36 weeks ended September 7, 2024, we recorded a pre-tax charge of $184 million ($141 million after-tax or $0.10 per share) associated with a previously announced voluntary recall of certain bars and cereals in our PFNA segment (Quaker Recall) with $174 million recorded in cost of sales related to property, plant and equipment write-offs, employee severance costs and other costs, $7 million recorded in selling, general and administrative expenses and $3 million recorded in other pension and retiree medical benefits income, which is not included in operating profit.

(g)In the 36 weeks ended September 7, 2024, we recorded a pre-tax gain of $76 million ($57 million after-tax or $0.04 per share) in selling, general and administrative expenses as a result of the sale of a corporate asset.

***Disaggregation of Net Revenue***

Our primary performance obligation is the distribution and sales of beverage and convenient food products to our customers. The following tables reflect the percentage of net revenue generated between our beverage business and our convenient food business:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** |
| | **9/6/2025** | **9/6/2025** | 9/7/2024 | 9/7/2024 |
| | **Beverages**<sup>(a)</sup> | **Convenient Foods** | Beverages<sup>(a)</sup> | Convenient Foods |
| North America | **53%** | **47%** | 52% | 48% |
| International <sup>(b)</sup> | **33%** | **67%** | 32% | 68% |
| PepsiCo | **45%** | **55%** | 44% | 56% |

---

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | **9/6/2025** | 9/7/2024 | 9/7/2024 |
| | **Beverages**<sup>(a)</sup> | **Convenient Foods** | Beverages<sup>(a)</sup> | Convenient Foods |
| North America | **51%** | **49%** | 51% | 49% |
| International <sup>(b)</sup> | **32%** | **68%** | 30% | 70% |
| PepsiCo | **43%** | **57%** | 43% | 57% |

---

(a)Beverage revenue from company-owned bottlers, which includes our consolidated bottling operations in our PBNA and EMEA segments, was 38% and 37% of our consolidated net revenue in the 12 and 36 weeks ended September 6, 2025, respectively, and 37% and 36% of our consolidated net revenue in the 12 and 36 weeks ended September 7, 2024, respectively. Generally, our finished goods beverage operations produce higher net revenue but lower operating margins as compared to concentrate sold to authorized bottling partners for the manufacture of finished goods beverages.

(b)Beverage and convenient foods revenue generated from our EMEA segment was 41% and 59% of EMEA net revenue, respectively, in the 12 weeks ended September 6, 2025, 38% and 62% of EMEA net revenue, respectively, in the 36 weeks ended September 6, 2025, 39% and 61% of EMEA net revenue, respectively, in the 12 weeks ended September 7, 2024 and 36% and 64% of EMEA net revenue, respectively, in the 36 weeks ended September 7, 2024.

***Other Segment Information***

Capital spending, amortization of intangible assets, and depreciation and other amortization of each segment are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** |
| | **Capital Spending**<sup>(a)</sup> | **Capital Spending**<sup>(a)</sup> | **Amortization of <br>Intangible Assets** | **Amortization of <br>Intangible Assets** | **Depreciation and<br>Other Amortization** | **Depreciation and<br>Other Amortization** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| PFNA | $**220** | $253 | $**4** | $2 | $**233** | $190 |
| PBNA | **278** | 313 | **7** | 5 | **229** | 234 |
| IB Franchise | **31** | 33 | **4** | 4 | **25** | 24 |
| EMEA | **167** | 189 | **4** | 4 | **138** | 117 |
| LatAm Foods | **178** | 207 | **—** |  | **105** | 96 |
| Asia Pacific Foods | **60** | 96 | **2** | 2 | **36** | 32 |
| Total segment | **934** | 1091 | **21** | 17 | **766** | 693 |
| Corporate | **58** | 58 | **—** |  | **37** | 29 |
| Total | $**992** | $1149 | $**21** | $17 | $**803** | $722 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **Capital Spending**<sup>(a)</sup> | **Capital Spending**<sup>(a)</sup> | **Amortization of <br>Intangible Assets** | **Amortization of <br>Intangible Assets** | **Depreciation and<br>Other Amortization** | **Depreciation and<br>Other Amortization** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| PFNA | $**645** | $788 | $**12** | $8 | $**665** | $564 |
| PBNA | **809** | 791 | **17** | 15 | **713** | 713 |
| IB Franchise | **77** | 77 | **11** | 11 | **64** | 61 |
| EMEA | **354** | 436 | **10** | 11 | **348** | 303 |
| LatAm Foods | **339** | 413 | **1** | 1 | **266** | 262 |
| Asia Pacific Foods | **152** | 167 | **5** | 5 | **94** | 81 |
| Total segment | **2376** | 2672 | **56** | 51 | **2150** | 1984 |
| Corporate | **123** | 178 | **—** |  | **109** | 83 |
| Total | $**2499** | $2850 | $**56** | $51 | $**2259** | $2067 |

---

(a) Asset and other balance sheet information for segments is not provided to our chief operating decision maker.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Note 2 - Recently Issued Accounting Pronouncements**

***Not Yet Adopted***

In September 2025, the Financial Accounting Standards Board (FASB) issued guidance to improve the accounting for costs related to internal-use software. The new guidance eliminates project stages and requires capitalizing software costs to begin when (1) management has authorized and committed to funding the software project and (2) it is probable that the project will be completed and the software will be used to perform the function intended. When evaluating if a project is probable to be completed, significant development uncertainty must be assessed. Additionally, disclosures for property, plant and equipment will be required for all capitalized software costs. The guidance is effective in the first quarter of 2028 with early adoption permitted as of the beginning of an annual reporting period. Upon adoption, the guidance may be applied prospectively, retrospectively or using a modified transition approach. We are evaluating the impact of this guidance on our consolidated financial statements.

In July 2025, the FASB issued guidance to provide for a practical expedient that an entity may assume that conditions as of the balance sheet date remain unchanged over the remaining life of the asset when estimating expected credit losses for current accounts receivable and current contract assets arising from revenue transactions from contracts with customers. The guidance is effective in the first quarter of 2026 with early adoption permitted, to be applied on a prospective basis. We are evaluating the impact of electing this practical expedient on our consolidated financial statements.

In November 2024, the FASB issued guidance to improve the disclosure of expenses in commonly presented expense captions. The new guidance requires a public entity to provide tabular disclosure, on an annual and interim basis, of amounts for the following expense categories: (1) purchases of inventory, (2) employee compensation, (3) depreciation and (4) intangible asset amortization, as included in each relevant expense caption. A relevant expense caption is an expense caption presented on the face of the income statement that contains any of the expense categories noted. Additionally, on an annual and interim basis, a qualitative description is required for amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. The guidance also requires certain amounts that are currently required to be disclosed to be included in the same tabular disclosure as these disaggregation requirements. Furthermore, on an annual and interim basis, a public entity is required to separately disclose selling expenses and annually, disclose a description of the selling expenses. The guidance is effective for 2027 annual reporting, and in the first quarter of 2028 for interim reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted. We will adopt the guidance when it becomes effective, in our 2027 annual reporting and each quarter thereafter, on a prospective basis.

In December 2023, the FASB issued guidance to enhance transparency of income tax disclosures. On an annual basis, the new guidance requires a public entity to disclose: (1) specific categories in the rate reconciliation, (2) additional information for reconciling items that are equal to or greater than 5% of the amount computed by multiplying income (or loss) from continuing operations before income tax expense (or benefit) by the applicable statutory income tax rate, (3) income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes, with foreign taxes disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5% of total income taxes paid, (4) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and (5) income tax expense (or benefit) from continuing operations disaggregated between federal (national), state and foreign. The guidance is effective for fiscal year 2025 annual reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted. We will adopt the guidance when it becomes effective, in our 2025 annual reporting, on a prospective basis.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Note 3 - Restructuring and Impairment Charges**

***2019 Multi-Year Productivity Plan (2019 Productivity Plan)***

The 2019 Productivity Plan leverages new technology and business models to further simplify, harmonize and automate processes; re-engineers our go-to-market and information systems, including deploying the right automation for each market; and simplifies our organization and optimizes our manufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan, in 2024, we further expanded and extended the plan through the end of 2030 to take advantage of additional opportunities within the initiatives described above. As a result, we expect to incur pre-tax charges of approximately $6.15 billion, including cash expenditures of approximately $5.1 billion. These pre-tax charges are expected to consist of approximately 50% of severance and other employee-related costs, 10% for asset impairments (all non-cash) resulting from plant closures and related actions, and 40% for other costs associated with the implementation of our initiatives.

The total plan pre-tax charges are expected to be incurred by segment approximately as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **PFNA** | **PBNA** | **IB Franchise** | **EMEA** | **LatAm Foods** | **Asia Pacific Foods** | **Corporate** |
| Expected pre-tax charges | 20% | 25% | 2% | 25% | 10% | 3% | 15% |

---

A summary of our 2019 Productivity Plan charges is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Cost of sales | $**16** | $10 | $**119** | $16 |
| Selling, general and administrative expenses | **126** | 214 | **435** | 363 |
| Impairment of intangible assets |  | 14 |  | 14 |
| Other pension and retiree medical benefits (income)/expense <sup>(a)</sup> | **(1)** | 7 | **13** | 22 |
| Total restructuring and impairment charges | $**141** | $245 | $**567** | $415 |
| After-tax amount | $**116** | $195 | $**467** | $325 |
| Impact on net income attributable to PepsiCo per common share | $**(0.08)** | $(0.14) | $**(0.34)** | $(0.24) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 | **Plan-to-Date**<br>**through 9/6/2025** |
| PFNA | $**32** | $8 | $**147** | $47 | $**579** |
| PBNA | **19** | 128 | **192** | 143 | **697** |
| IB Franchise | **2** | 15 | **7** | 15 | **58** |
| EMEA | **69** | 35 | **118** | 75 | **879** |
| LatAm Foods | **17** | 11 | **36** | 32 | **283** |
| Asia Pacific Foods | **5** | 2 | **9** | 6 | **96** |
| Corporate <sup>(a)</sup> | **(2)** | 39 | **45** | 75 | **463** |
|  | **142** | 238 | **554** | 393 | **3055** |
| Other pension and retiree medical benefits (income)/expense <sup>(a)</sup> | **(1)** | 7 | **13** | 22 | **139** |
| Total | $**141** | $245 | $**567** | $415 | $**3194** |

---

(a)Income amount represents adjustments for changes in estimates of previously recorded amounts.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 | **Plan-to-Date**<br>**through 9/6/2025** |
| Severance and other employee costs | $**46** | $151 | $**168** | $233 | $**1602** |
| Asset impairments | **22** | 30 | **109** | 34 | **415** |
| Other costs | **73** | 64 | **290** | 148 | **1177** |
| Total | $**141** | $245 | $**567** | $415 | $**3194** |

---

Severance and other employee costs primarily include severance and other termination benefits, as well as voluntary separation arrangements. Other costs primarily include costs associated with the implementation of our initiatives, including contract termination costs, consulting and other professional fees.

A summary of our 2019 Productivity Plan activity for the 36 weeks ended September 6, 2025 is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Severance and Other Employee Costs** | **Asset <br>Impairments** | **Other Costs** | **Total** |
| Liability as of December 28, 2024 | $338 | $— | $26 | $364 |
| 2025 restructuring charges | 168 | 109 | 290 | 567 |
| Cash payments <sup>(a)</sup> | (245) |  | (309) | (554) |
| Non-cash charges and translation | (1) | (109) | (1) | (111) |
| Liability as of September 6, 2025 | $**260** | $**—** | $**6** | $**266** |

---

(a)Excludes cash expenditures of $8 million reported in the cash flow statement in pension and retiree medical contributions.

The majority of the restructuring accrual at September 6, 2025 is expected to be paid within a year.

***Other Productivity Initiatives***

There were no material charges related to other productivity and efficiency initiatives outside the scope of the 2019 Productivity Plan.

We regularly evaluate different productivity initiatives beyond the productivity plan and other initiatives described above.

For information on additional impairment charges, see Notes 1 and 4 for impairment and other charges taken primarily related to the impairments of the Rockstar and Be & Cheery brands.

**Note 4 - Intangible Assets**

A summary of our amortizable intangible assets is as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **9/6/2025** | **9/6/2025** | **9/6/2025** | 12/28/2024 | 12/28/2024 | 12/28/2024 |
| | **Gross** | **Accumulated Amortization** | **Net** | Gross | Accumulated Amortization | Net |
| Acquired franchise rights  | $**833** | $**(239)** | $**594** | $821 | $(223) | $598 |
| Customer relationships <sup>(a)</sup> | **766** | **(330)** | **436** | 565 | (279) | 286 |
| Brands | **1080** | **(1013)** | **67** | 1051 | (977) | 74 |
| Other identifiable intangibles | **433** | **(289)** | **144** | 420 | (276) | 144 |
| Total | $**3112** | $**(1871)** | $**1241** | $2857 | $(1755) | $1102 |

---

(a)Increase is primarily related to acquisitions of VNGR Beverage, LLC (poppi) and Garza Food Ventures LLC (Siete). See Note 12 for further information on acquisitions.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

The components of indefinite-lived intangible assets are as follows:

---

| | | |
|:---|:---|:---|
| | **9/6/2025** | 12/28/2024 |
| Goodwill | $**18845** | $17534 |
| Other indefinite-lived intangible assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Reacquired franchise rights | **7532** | 7437 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquired franchise rights | **1886** | 1858 |
| &nbsp;&nbsp;&nbsp;&nbsp;Brands <sup>(a)</sup> | **4193** | 4404 |
| Total indefinite-lived intangible assets | $**32456** | $31233 |

---

(a)Decrease is primarily related to impairments to the Rockstar and Be & Cheery brands as well as the sale of the Rockstar brand in connection with the transaction described below, partially offset by acquisitions of poppi and Siete. See Note 12 for further information on acquisitions.

During the 36 weeks ended September 6, 2025, recent business performance in conjunction with lower expectations of future business performance compared to projections, as well as the transaction discussed below, indicated a deterioration of the significant inputs used to determine the fair value of our indefinite-lived intangible assets in certain markets and required us to perform quantitative assessments on certain assets. The fair value of our indefinite-lived intangible assets was estimated using discounted cash flows under the income approach, which we consider to be a Level 3 (significant unobservable inputs) measurement. We determined that the carrying value exceeded the fair value, which reflected our most current estimates of future sales and their contributions to operating profit and expected future cash flows (including perpetuity growth assumptions), as well as an increase in the weighted-average cost of capital. As a result of the quantitative assessments, in the 36 weeks ended September 6, 2025, we recorded pre-tax impairment charges of $1.9 billion ($1.5 billion after-tax or $1.07 per share) in impairment of intangible assets primarily comprised of the Rockstar brand in our PBNA, EMEA, and IB Franchise segments, with $0.1 billion ($0.1 billion after-tax or $0.06 per share) recorded during the 12 weeks ended September 6, 2025 related to the Rockstar brand in our IB Franchise and PBNA segments. For further information on our policies for indefinite-lived intangible assets, see Note 2 to our consolidated financial statements in our Recast Segment Information.

On August 28, 2025, we consummated a transaction with Celsius Holdings, Inc. (Celsius), pursuant to which we acquired convertible preferred shares and transferred cash and certain non-cash assets, primarily the Rockstar brand of $0.5 billion in the United States and Canada (Celsius Transaction). For further information on the convertible preferred shares, see Note 9. On the same date, we entered into an agreement with Celsius to be the exclusive distributor for the Alani Nu brand in certain channels in the United States and Canada for approximately $0.2 billion, to start in the fourth quarter of 2025.

The change in the book value of goodwill is as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **PFNA** | **PBNA** | **IB Franchise** | **EMEA**<sup>(b)</sup> | **LatAm Foods** | **Asia Pacific Foods** | **Total** |
| Balance as of December 28, 2024 | $791 | $11925 | $1918 | $2194 | $354 | $352 | $17534 |
| Acquisitions <sup>(a)</sup> | 625 | 179 |  |  |  |  | 804 |
| Translation and other | 5 | 18 | 3 | 442 | 25 | 14 | 507 |
| Balance as of September 6, 2025 | $**1421** | $**12122** | $**1921** | $**2636** | $**379** | $**366** | $**18845** |

---

(a)Related to the acquisitions of Siete in our PFNA segment and poppi in our PBNA segment. See Note 12 for further information on acquisitions.

(b)Translation and other primarily reflects the appreciation of the Russian ruble and the euro.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Note 5 - Income Taxes**

Numerous countries, including European Union member states, have enacted, or are expected to enact, legislation incorporating the Organization for Economic Co-operation and Development (OECD) model rules for a global minimum tax rate of 15%. Widespread implementation is expected by the end of 2025, with certain countries that have not yet enacted potentially applying the legislation as of a retroactive date. Legislation enacted as of September 6, 2025 did not have a material impact on our financial statements for the 12 and 36 weeks ended September 6, 2025 and is not expected to have a material impact on our 2025 financial statements.

On July 4, 2025, the One Big Beautiful Bill (OBBB) Act, which includes a broad range of tax reform provisions, was signed into law in the United States. We do not expect the OBBB Act to have a material impact on our estimated annual effective tax rate in 2025.

**Note 6 - Share-Based Compensation**

The following table summarizes our total share-based compensation expense, which is primarily recorded in selling, general and administrative expenses:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Share-based compensation expense – equity awards | $**76** | $77 | $**207** | $260 |
| Share-based compensation expense – liability awards | **2** | 4 | **(1)** | 14 |
| Restructuring charges | **(1)** | (1) | **(3)** | (5) |
| Total | $**77** | $80 | $**203** | $269 |

---

The following table summarizes share-based awards granted under the terms of the PepsiCo, Inc. Long-Term Incentive Plan:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | **9/6/2025** | 9/7/2024 | 9/7/2024 |
| | **Granted**<sup>(a)</sup> | **Weighted-Average Grant Price** | Granted<sup>(a)</sup> | Weighted-Average Grant Price |
| Stock options | **1.7** | $**150.75** | 2.0 | $164.28 |
| RSUs and PSUs | **2.1** | $**153.50** | 2.3 | $164.25 |

---

(a)In millions. All grant activity is disclosed at target.

We granted long-term cash awards to certain executive officers and other senior executives with an aggregate target value of $22 million and $19 million during the 36 weeks ended September 6, 2025 and September 7, 2024, respectively.

For the 12 weeks ended September 6, 2025 and September 7, 2024, our grants of stock options, RSUs, PSUs and long-term cash awards were nominal.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

Our weighted-average Black-Scholes fair value assumptions are as follows:

---

| | | |
|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 |
| Expected life | **7 years** | 7 years |
| Risk-free interest rate | **4.1%** | 4.2% |
| Expected volatility | **16%** | 16% |
| Expected dividend yield | **3.5%** | 2.9% |

---

**Note 7 - Pension and Retiree Medical Benefits**

The components of net periodic benefit cost/(income) for pension and retiree medical plans are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** |
| | **Pension** | **Pension** | **Pension** | **Pension** | **Retiree Medical** | **Retiree Medical** |
| | **U.S.** | **U.S.** | **International** | **International** | | |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |<br>**9/6/2025** |<br>9/7/2024 |
| Service cost | $**71** | $80 | $**11** | $11 | $**8** | $7 |
| ***Other pension and retiree medical benefits income:*** | ***Other pension and retiree medical benefits income:*** | ***Other pension and retiree medical benefits income:*** | ***Other pension and retiree medical benefits income:*** | ***Other pension and retiree medical benefits income:*** |  |  |
| Interest cost | $**136** | $135 | $**35** | $36 | $**6** | $7 |
| Expected return on plan assets | **(186)** | (201) | **(46)** | (50) | **(3)** | (3) |
| Amortization of prior service cost/(credits) | **1** | (6) | **(1)** |  | **(1)** | (1) |
| Amortization of net losses/(gains) | **19** | 17 | **7** | 6 | **(5)** | (6) |
| Settlement/curtailment losses | **5** | 8 | **8** | 7 | **—** |  |
| Special termination benefits | **(1)** | 8 | **—** |  | **—** | 2 |
| Total other pension and retiree medical benefits income | $**(26)** | $(39) | $**3** | $(1) | $**(3)** | $(1) |
| Total | $**45** | $41 | $**14** | $10 | $**5** | $6 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **Pension** | **Pension** | **Pension** | **Pension** | **Retiree Medical** | **Retiree Medical** |
| | **U.S.** | **U.S.** | **International** | **International** | | |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Service cost | $**216** | $240 | $**30** | $32 | $**22** | $22 |
| ***Other pension and retiree medical benefits income:*** | ***Other pension and retiree medical benefits income:*** | ***Other pension and retiree medical benefits income:*** | ***Other pension and retiree medical benefits income:*** | ***Other pension and retiree medical benefits income:*** |  |  |
| Interest cost | $**406** | $405 | $**97** | $99 | $**20** | $22 |
| Expected return on plan assets | **(558)** | (604) | **(129)** | (139) | **(8)** | (9) |
| Amortization of prior service cost/(credits) | **2** | (17) | **(1)** | (1) | **(3)** | (3) |
| Amortization of net losses/(gains) | **58** | 53 | **17** | 15 | **(17)** | (18) |
| Net settlement/curtailment losses | **5** | 8 | **7** | 9 | **—** |  |
| Special termination benefits | **13** | 23 | **—** |  | **—** | 2 |
| Total other pension and retiree medical benefits income | $**(74)** | $(132) | $**(9)** | $(17) | $**(8)** | $(6) |
| Total | $**142** | $108 | $**21** | $15 | $**14** | $16 |

---

We regularly evaluate opportunities to reduce risk and volatility associated with our pension and retiree medical plans.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

In the 36 weeks ended September 6, 2025 and September 7, 2024, we made discretionary contributions of $250 million and $150 million, respectively, to our U.S. qualified defined benefit plans, and $29 million and $27 million, respectively, to our international defined benefit plans.

**Note 8 - Debt Obligations** 

In the 36 weeks ended September 6, 2025, we issued the following notes:

---

| | | | |
|:---|:---|:---|:---|
| **Interest Rate** | **Maturity Date** | **Principal Amount**<sup>(a)</sup> | **Principal Amount**<sup>(a)</sup> |
| 4.400% | February 2027 | $500 |  |
| 4.450% | February 2028 | $750 |  |
| 4.600% | February 2030 | $1000 |  |
| 5.000% | February 2035 | $1250 |  |
| 4.100% | January 2029 | $750 |  |
| 4.300% | July 2030 | $650 |  |
| 4.650% | July 2032 | $850 |  |
| 5.000% | July 2035 | $1250 |  |
| 3.450% | July 2037 | 500 | (b) |
| 4.050% | July 2055 | 500 | (b) |

---

(a)Excludes debt issuance costs, discounts and premiums.

(b)These notes, issued in euros, were designated as net investment hedges to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.

The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper.

In the 36 weeks ended September 6, 2025, $3.2 billion of U.S. dollar-denominated senior notes matured and were paid.

As of September 6, 2025, we had $3.0 billion of commercial paper outstanding, excluding discounts.

In the 36 weeks ended September 6, 2025, we entered into a new five-year unsecured revolving credit agreement (2025 Five-Year Credit Agreement), which expires on May 23, 2030. The 2025 Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $5.0 billion in U.S. dollars and/or euros, including a $0.75 billion swing line subfacility for euro-denominated borrowings permitted to be borrowed on a same-day basis, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $5.75 billion (or the equivalent amount in euros). Additionally, we may, up to two times during the term of the 2025 Five-Year Credit Agreement, request renewal of the agreement for an additional one-year period. The 2025 Five-Year Credit Agreement replaced our $5.0 billion five-year credit agreement, dated as of May 24, 2024.

Also in the 36 weeks ended September 6, 2025, we entered into a new 364-day unsecured revolving credit agreement (2025 364-Day Credit Agreement), which expires on May 22, 2026. The 2025 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $5.0 billion in U.S. dollars and/or euros, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $5.75 billion (or the equivalent amount in euros). We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which term loan would mature no later than the anniversary of the then effective termination date. The 2025 364-Day Credit Agreement replaced our $5.0 billion 364-day credit agreement, dated as of May 24, 2024.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

Funds borrowed under the 2025 Five-Year Credit Agreement and the 2025 364-Day Credit Agreement may be used for general corporate purposes. Subject to certain conditions, we may borrow, prepay and reborrow amounts under these agreements. As of September 6, 2025, there were no outstanding borrowings under the 2025 Five-Year Credit Agreement or the 2025 364-Day Credit Agreement.

**Note 9 - Financial Instruments**

We are exposed to market risks arising from adverse changes in:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• commodity prices, affecting the cost of our raw materials and energy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• foreign exchange rates and currency restrictions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• interest rates.

There have been no material changes during the 36 weeks ended September 6, 2025 with respect to our risk management policies or strategies and valuation techniques used in measuring the fair value of the financial assets or liabilities disclosed in Note 9 to our consolidated financial statements in our Recast Segment Information.

Certain of our agreements with our counterparties require us to post full collateral on derivative instruments in a net liability position if our credit rating is at A2 (Moody's Investors Service, Inc.) or A (S&P Global Ratings) and we have been placed on credit watch for possible downgrade or if our credit rating falls below either of these levels. The fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of September 6, 2025 was $88 million. We have posted no collateral under these contracts and no credit-risk-related contingent features were triggered as of September 6, 2025.

The notional amounts of our financial instruments used to hedge the above risks are as follows:

---

| | | |
|:---|:---|:---|
| | **Notional Amounts**<sup>(a)</sup> | **Notional Amounts**<sup>(a)</sup> |
| | **9/6/2025** | 12/28/2024 |
| Commodity contracts | $**1.3** | $1.4 |
| Interest rate swap contracts | $**2.0** | $2.0 |
| Foreign exchange contracts | $**3.2** | $3.1 |
| Cross-currency contracts | $**1.7** | $1.2 |
| Non-derivative debt instruments | $**4.3** | $2.9 |

---

(a)In billions.

As of September 6, 2025 and December 28, 2024, approximately 13% of total debt was subject to variable rates, after the impact of the related interest rate swap contracts.

***Debt Securities***

*Available-for-Sale*

On August 28, 2025, as part of the Celsius Transaction described in Note 4, we acquired Series B convertible preferred shares, issued by Celsius, valued at $585 million upon acquisition, excluding acquisition-related charges. These Series B convertible preferred shares include certain conversion and redemption features and convert into Celsius common shares after six years from issuance if certain market-based conditions are met, or can be redeemed for cash after seven years from issuance. Shares underlying the transaction were priced at $51.75 per share, and the preferred shares are entitled to a 5% annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as a Level 3 investment in available-for-sale debt securities, consistent with the Series A convertible preferred shares issued by Celsius that we currently hold. In addition, as part of this transaction, the conversion and redemption periods of the Series A convertible

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

preferred shares were extended to match the terms of the newly issued Series B convertible preferred shares, which was accounted for as a modification.

The activity related to our Level 3 investments in certain available-for-sale debt securities is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| ***Celsius:*** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance, beginning of period | $**958** | $1337 | $**785** | $1156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquired | **590** |  | **590** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gain/(loss) | **535** | (453) | **722** | (265) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash dividends received | **(6)** | (7) | **(20)** | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance, end of period | $**2077** | $877 | $**2077** | $877 |
| ***Other:*** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance, beginning of period | $**261** | $— | $**256** | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gain/(loss) | **6** |  | **11** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance, end of period | $**267** | $— | $**267** | $— |
| Total Level 3 available-for-sale balance, end of period | $**2344** | $877 | $**2344** | $877 |

---

There were no impairment charges related to our investments in available-for-sale debt securities in both the 36 weeks ended September 6, 2025 and September 7, 2024. There were unrealized gains of $1,067 million and $347 million as of September 6, 2025 and September 7, 2024, respectively, associated with our available-for-sale debt securities.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

***Recurring Fair Value Measurements***

The fair values of our financial assets and liabilities are categorized as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **9/6/2025** | **9/6/2025** | 12/28/2024 | 12/28/2024 |
| |<br>**Fair Value Hierarchy Levels**<sup>(a)</sup> | **Assets**<sup>(a)</sup> | **Liabilities**<sup>(a)</sup> | Assets<sup>(a)</sup> | Liabilities<sup>(a)</sup> |
| Available-for-sale debt securities <sup>(b)</sup> | **3** | $**2344** | $**—** | $1041 | $— |
| Index funds <sup>(c)</sup> | **1** | $**325** | $**—** | $336 | $— |
| Prepaid forward contracts <sup>(d)</sup> | **2** | $**9** | $**—** | $15 | $— |
| Deferred compensation <sup>(e)</sup> | **2** | $**—** | $**485** | $— | $503 |
| Contingent consideration <sup>(f)</sup> | **3** | $**—** | $**180** | $— | $— |
| ***Derivatives designated as fair value hedging instruments:*** | ***Derivatives designated as fair value hedging instruments:*** | ***Derivatives designated as fair value hedging instruments:*** | ***Derivatives designated as fair value hedging instruments:*** |  |  |
| Interest rate swap contracts <sup>(g)</sup> | **2** | $**31** | $**1** | $— | $46 |
| ***Derivatives designated as cash flow hedging instruments:*** | ***Derivatives designated as cash flow hedging instruments:*** | ***Derivatives designated as cash flow hedging instruments:*** | ***Derivatives designated as cash flow hedging instruments:*** |  |  |
| Foreign exchange contracts <sup>(h)</sup> | **2** | $**8** | $**32** | $55 | $3 |
| Cross-currency contracts <sup>(h)</sup> | **2** | **—** | **105** |  | 165 |
| Commodity contracts <sup>(i)</sup> | **2** | **86** | **8** | 27 | 6 |
|  |  | $**94** | $**145** | $82 | $174 |
| ***Derivatives designated as net investment hedging instruments:*** | ***Derivatives designated as net investment hedging instruments:*** | ***Derivatives designated as net investment hedging instruments:*** | ***Derivatives designated as net investment hedging instruments:*** |  |  |
| Cross-currency contracts <sup>(h)</sup> | **2** | $**—** | $**16** | $1 | $4 |
| ***Derivatives not designated as hedging instruments:*** | ***Derivatives not designated as hedging instruments:*** | ***Derivatives not designated as hedging instruments:*** | ***Derivatives not designated as hedging instruments:*** |  |  |
| Foreign exchange contracts <sup>(h)</sup> | **2** | $**6** | $**12** | $28 | $12 |
| Commodity contracts <sup>(i)</sup> | **2** | **1** | **11** | 3 | 10 |
|  |  | $**7** | $**23** | $31 | $22 |
| Total derivatives at fair value <sup>(j)</sup> |  | $**132** | $**185** | $114 | $246 |
| **Total** |  | $**2810** | $**850** | $1506 | $749 |

---

(a)Fair value hierarchy levels are categorized consistently by Level 1 (quoted prices in active markets for identical assets), Level 2 (significant other observable inputs) and Level 3 in both years. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities.

(b)Classified as other assets. Includes $2,077 million and $785 million related to our investment in Celsius as of September 6, 2025 and December 28, 2024, respectively; also, includes $267 million and $256 million related to our other investment in available-for-sale debt securities as of September 6, 2025 and December 28, 2024, respectively. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80% probability that a certain market-based condition will be met and an average estimated discount rate of 10.1% and 7.3% as of September 6, 2025 and December 28, 2024, respectively. The fair value of the other Level 3 investment is estimated using a lattice model primarily based on the underlying stock price, volatility and certain significant unobservable inputs, such as a discount rate of 8.3% based on an estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement.

(c)Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.

(d)Based primarily on the price of our common stock.

(e)Based on the fair value of investments corresponding to employees' investment elections.

(f)In connection with our acquisition of poppi, we recorded a liability at fair value for the contingent consideration payable upon achievement of certain performance milestones by the third quarter of 2027, with a maximum payment of $300 million. If these performance milestones are not met, no payment will be made. The fair value of the liability is estimated using discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as forecasts of net revenue and margin. An increase in the net revenue and margin forecasts would result in a higher fair value measurement, while a decrease in the net revenue and margin forecasts would result in a lower fair value measurement.

(g)Based on Secured Overnight Financing Rate forward rates. As of September 6, 2025, the carrying amount of hedged fixed-rate debt was $2.0 billion, which was classified on the balance sheet within long-term debt obligations.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

(h)Based on recently reported market transactions of spot and forward rates.

(i)Primarily based on recently reported market transactions of swap arrangements.

(j)Derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on our balance sheet as of September 6, 2025 and December 28, 2024 were not material. Collateral received or posted against our asset or liability positions was not material. Exchange-traded commodity futures are cash-settled on a daily basis and, therefore, not included in the table.

The carrying amounts of our cash and cash equivalents and short-term investments recorded at amortized cost approximate fair value (classified as Level 2 in the fair value hierarchy) due to their short-term maturity. The fair value of our debt obligations as of September 6, 2025 and December 28, 2024 was $48 billion and $40 billion, respectively, based upon prices of identical or similar instruments in the marketplace, which are considered Level 2 inputs.

Losses/(gains) on our fair value hedges recognized in the income statement are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Interest rate swap contracts <sup>(a)</sup> | $**(33)** | $— | $**(76)** | $— |

---

(a)Interest rate derivative losses/(gains) are included in net interest expense and other. These losses/(gains) are substantially offset by decreases/increases in the value of the underlying debt, which are also included in net interest expense and other.

Losses/(gains) on our cash flow hedges are categorized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** |
| | **Losses/(Gains)<br>Recognized in<br>Accumulated Other<br>Comprehensive Loss** | **Losses/(Gains)<br>Recognized in<br>Accumulated Other<br>Comprehensive Loss** | **Losses/(Gains)**<br>**Reclassified from**<br>**Accumulated Other**<br>**Comprehensive Loss**<br>**into Income Statement**<sup>(a)</sup> | **Losses/(Gains)**<br>**Reclassified from**<br>**Accumulated Other**<br>**Comprehensive Loss**<br>**into Income Statement**<sup>(a)</sup> |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Foreign exchange contracts  | $**8** | $(33) | $**13** | $(3) |
| Cross-currency contracts | **(5)** | (15) | **(8)** | (21) |
| Commodity contracts | **(38)** | 75 | **(10)** | 34 |
| Total | $**(35)** | $27 | $**(5)** | $10 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **Losses/(Gains)<br>Recognized in<br>Accumulated Other<br>Comprehensive Loss** | **Losses/(Gains)<br>Recognized in<br>Accumulated Other<br>Comprehensive Loss** | **Losses/(Gains)**<br>**Reclassified from**<br>**Accumulated Other**<br>**Comprehensive Loss**<br>**into Income Statement**<sup>(a)</sup> | **Losses/(Gains)**<br>**Reclassified from**<br>**Accumulated Other**<br>**Comprehensive Loss**<br>**into Income Statement**<sup>(a)</sup> |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Foreign exchange contracts  | $**78** | $(48) | $**(11)** | $15 |
| Cross-currency contracts | **(60)** | 19 | **(63)** | 14 |
| Commodity contracts | **(138)** | 103 | **(15)** | 85 |
| Total | $**(120)** | $74 | $**(89)** | $114 |

---

(a)Foreign exchange derivative losses/(gains) are included in net revenue and cost of sales. Cross-currency interest rate swap derivative losses/(gains) are included in selling, general and administrative expenses. Commodity derivative losses/(gains) are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. See Note 11 for further information.

As of September 6, 2025, we expect to reclassify net gains of $74 million related to our cash flow hedges from accumulated other comprehensive loss within common shareholders' equity into net income during the next 12 months.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

Losses/(gains) on our net investment hedges are categorized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** |
| | **Losses/(Gains)<br>Recognized in<br>Accumulated Other<br>Comprehensive Loss** | **Losses/(Gains)<br>Recognized in<br>Accumulated Other<br>Comprehensive Loss** | **Losses/(Gains)** <br>**Recognized in Income Statement**<sup>(a)</sup> | **Losses/(Gains)** <br>**Recognized in Income Statement**<sup>(a)</sup> |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Non-derivative debt instruments | $**27** | $114 | $**—** | $— |
| Cross-currency contracts | **4** | 13 | **(3)** | (2) |
| Foreign exchange contracts  | **(13)** | **—** | **—** | **—** |
| Total | $**18** | $127 | $**(3)** | $(2) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **Losses/(Gains)<br>Recognized in<br>Accumulated Other<br>Comprehensive Loss** | **Losses/(Gains)<br>Recognized in<br>Accumulated Other<br>Comprehensive Loss** | **Losses/(Gains)**<br>**Recognized in Income Statement**<sup>(a)</sup> | **Losses/(Gains)**<br>**Recognized in Income Statement**<sup>(a)</sup> |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Non-derivative debt instruments | $**311** | $45 | $**—** | $— |
| Cross-currency contracts | **13** | 13 | **(7)** | (2) |
| Foreign exchange contracts  | **(13)** | **—** | **—** | **—** |
| Total | $**311** | $58 | $**(7)** | $(2) |

---

(a)Amount excluded from the assessment of effectiveness recognized in earnings associated with cross-currency interest rate swaps.

Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** |
| | **9/6/2025** | **9/6/2025** | **9/6/2025** | 9/7/2024 | 9/7/2024 | 9/7/2024 |
| | **Cost of sales** | **Selling, general and administrative expenses** | **Total** | Cost of sales | Selling, general and administrative expenses | Total |
| Foreign exchange contracts | $**—** | $**(3)** | $**(3)** | $1 | $(8) | $(7) |
| Commodity contracts | **16** | **4** | **20** | 24 | 36 | 60 |
| Total | $**16** | $**1** | $**17** | $25 | $28 | $53 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | **9/6/2025** | **9/6/2025** | 9/7/2024 | 9/7/2024 | 9/7/2024 |
| | **Cost of sales** | **Selling, general and administrative expenses** | **Total** | Cost of sales | Selling, general and administrative expenses | Total |
| Foreign exchange contracts | $**1** | $**51** | $**52** | $1 | $34 | $35 |
| Commodity contracts | **12** | **(6)** | **6** | 9 | 16 | 25 |
| Total | $**13** | $**45** | $**58** | $10 | $50 | $60 |

---

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Note 10 - Net Income Attributable to PepsiCo per Common Share**

The computations of basic and diluted net income attributable to PepsiCo per common share are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** |
| | **9/6/2025** | **9/6/2025** | 9/7/2024 | 9/7/2024 |
| | **Income** | **Shares**<sup>(a)</sup> | Income | Shares<sup>(a)</sup> |
| Basic net income attributable to PepsiCo per common share | $**1.90** |  | $2.13 |  |
| Net income available for PepsiCo common shareholders | $**2603** | **1369** | $2930 | 1373 |
| Dilutive securities: |  |  |  |  |
| &nbsp;&nbsp;Stock options, RSUs, PSUs and other <sup>(b)</sup> | **—** | **3** |  | 5 |
| Diluted | $**2603** | **1372** | $2930 | 1378 |
| Diluted net income attributable to PepsiCo per common share | $**1.90** |  | $2.13 |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | **9/6/2025** | 9/7/2024 | 9/7/2024 |
| | **Income** | **Shares**<sup>(a)</sup> | Income | Shares<sup>(a)</sup> |
| Basic net income attributable to PepsiCo per common share | $**4.16** |  | $5.86 |  |
| Net income available for PepsiCo common shareholders | $**5700** | **1370** | $8055 | 1374 |
| Dilutive securities: |  |  |  |  |
| &nbsp;&nbsp;Stock options, RSUs, PSUs and other <sup>(b)</sup> | **—** | **3** |  | 5 |
| Diluted | $**5700** | **1373** | $8055 | 1379 |
| Diluted net income attributable to PepsiCo per common share | $**4.15** |  | $5.84 |  |

---

(a)Weighted-average common shares outstanding (in millions).

(b)The dilutive effect of these securities is calculated using the treasury stock method.

The weighted-average amount of antidilutive securities excluded from the calculation of diluted earnings per common share was 7 million and 8 million for the 12 and 36 weeks ended September 6, 2025, respectively, and 4 million for the 12 and 36 weeks ended September 7, 2024.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Note 11 - Accumulated Other Comprehensive Loss Attributable to PepsiCo**

The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Currency Translation Adjustment** | **Cash Flow Hedges** | **Pension and Retiree Medical** | **Available-for-Sale Debt Securities and Other**<sup>(a)</sup> | **Accumulated Other Comprehensive Loss Attributable to PepsiCo** |
| Balance as of December 28, 2024 <sup>(b)</sup> | $(15217) | $82 | $(2714) | $237 | $(17612) |
| Other comprehensive income/(loss) before reclassifications <sup>(c)</sup> | 410 | 58 | (4) | 87 | 551 |
| Amounts reclassified from accumulated other comprehensive loss |  | (31) | 17 |  | (14) |
| Net other comprehensive income | 410 | 27 | 13 | 87 | 537 |
| Tax amounts | 26 | (5) | (3) | (21) | (3) |
| Balance as of March 22, 2025 <sup>(b)</sup> | (14781) | 104 | (2704) | 303 | (17078) |
| Other comprehensive income/(loss) before reclassifications <sup>(d)</sup> | 915 | 27 | (42) | 84 | 984 |
| Amounts reclassified from accumulated other comprehensive loss  |  | (53) | 18 |  | (35) |
| Net other comprehensive income/(loss) | 915 | (26) | (24) | 84 | 949 |
| Tax amounts | 46 | 8 | 5 | (20) | 39 |
| Balance as of June 14, 2025 <sup>(b)</sup> | (13820) | 86 | (2723) | 367 | (16090) |
| Other comprehensive income/(loss) before reclassifications | 33 | 35 | (6) | 536 | 598 |
| Amounts reclassified from accumulated other comprehensive loss  |  | (5) | 33 |  | 28 |
| Net other comprehensive income | 33 | 30 | 27 | 536 | 626 |
| Tax amounts | 6 | (7) | (6) | (126) | (133) |
| Balance as of September 6, 2025 <sup>(b)</sup> | $**(13781)** | $**109** | $**(2702)** | $**777** | $**(15597)** |

---

(a)The movements primarily represent fair value changes in available-for-sale debt securities, including our investment in Celsius convertible preferred stock. See Note 9 for further information.

(b)Pension and retiree medical amounts are net of taxes of $1,282 million as of December 28, 2024, $1,279 million as of March 22, 2025, $1,284 million as of June 14, 2025 and $1,278 million as of September 6, 2025.

(c)Currency translation adjustment primarily reflects appreciation of the Russian ruble and deprecation of the euro.

(d)Currency translation adjustment primarily reflects appreciation of the Russian ruble, Mexican peso and Canadian dollar.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Currency Translation Adjustment | Cash Flow Hedges | Pension and Retiree Medical | Available-for-Sale Debt Securities and Other <sup>(a)</sup> | Accumulated Other Comprehensive Loss Attributable<br>to PepsiCo |
| Balance as of December 30, 2023 <sup>(b)</sup> | $(13255) | $(31) | $(2719) | $471 | $(15534) |
| Other comprehensive (loss)/income before reclassifications <sup>(c)</sup> | (168) | (47) | 4 | 685 | 474 |
| Amounts reclassified from accumulated other comprehensive loss |  | 51 | 9 |  | 60 |
| Net other comprehensive (loss)/income | (168) | 4 | 13 | 685 | 534 |
| Tax amounts | (14) | (1) | (2) | (162) | (179) |
| Balance as of March 23, 2024 <sup>(b)</sup> | (13437) | (28) | (2708) | 994 | (15179) |
| Other comprehensive (loss)/income before reclassifications <sup>(d)</sup> | (295) | 3 | (1) | (511) | (804) |
| Amounts reclassified from accumulated other comprehensive loss |  | 53 | 12 |  | 65 |
| Net other comprehensive (loss)/income | (295) | 56 | 11 | (511) | (739) |
| Tax amounts | 28 | (14) | (2) | 120 | 132 |
| Balance as of June 15, 2024 <sup>(b)</sup> | (13704) | 14 | (2699) | 603 | (15786) |
| Other comprehensive (loss)/income before reclassifications <sup>(e)</sup> | (544) | (34) |  | (460) | (1038) |
| Amounts reclassified from accumulated other comprehensive loss  |  | 7 | 25 |  | 32 |
| Net other comprehensive (loss)/income | (544) | (27) | 25 | (460) | (1006) |
| Tax amounts | 32 | 3 | (4) | 109 | 140 |
| Balance as of September 7, 2024 <sup>(b)</sup> | $(14216) | $(10) | $(2678) | $252 | $(16652) |

---

(a)The movements primarily represent fair value changes in available-for-sale debt securities, including our investment in Celsius convertible preferred stock. See Note 9 for further information.

(b)Pension and retiree medical amounts are net of taxes of $1,282 million as of December 30, 2023 and $1,280 million as of March 23, 2024, $1,278 million as of June 15, 2024 and $1,274 million as of September 7, 2024.

(c)Currency translation adjustment primarily reflects depreciation of the South African rand, Canadian dollar and Russian ruble.

(d)Currency translation adjustment primarily reflects depreciation of the Egyptian pound.

(e)Currency translation adjustment primarily reflects depreciation of the Mexican peso.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

The reclassifications from accumulated other comprehensive loss to the income statement are summarized as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |<br>**Affected Line Item in the Income Statement** |
| ***Cash flow hedges:*** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign exchange contracts | $**—** | $(1) | $**(2)** | $(1) | Net revenue |
| &nbsp;&nbsp;&nbsp;Foreign exchange contracts | **13** | (2) | **(9)** | 16 | Cost of sales |
| &nbsp;&nbsp;&nbsp;Cross-currency contracts | **(8)** | (21) | **(63)** | 14 | Selling, general and administrative expenses |
| &nbsp;&nbsp;&nbsp;Interest rate swap contracts | **—** | (3) | **—** | (3) | Selling, general and administrative expenses |
| &nbsp;&nbsp;&nbsp;Commodity contracts | **(11)** | 34 | **(17)** | 85 | Cost of sales |
| &nbsp;&nbsp;&nbsp;Commodity contracts | **1** |  | **2** |  | Selling, general and administrative expenses |
| &nbsp;&nbsp;&nbsp;Net (gains)/losses before tax | **(5)** | 7 | **(89)** | 111 |  |
| &nbsp;&nbsp;&nbsp;Tax amounts | **—** | (1) | **22** | (28) |  |
| &nbsp;&nbsp;&nbsp;Net (gains)/losses after tax | $**(5)** | $6 | $**(67)** | $83 |  |
| ***Pension and retiree medical items:*** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of net prior service credits | $**(1)** | $(7) | $**(2)** | $(21) | Other pension and retiree medical benefits income |
| &nbsp;&nbsp;&nbsp;Amortization of net losses | **21** | 17 | **58** | 50 | Other pension and retiree medical benefits income |
| &nbsp;&nbsp;&nbsp;Net settlement/curtailment losses | **13** | 15 | **12** | 17 | Other pension and retiree medical benefits income |
| &nbsp;&nbsp;&nbsp;Net losses before tax | **33** | 25 | **68** | 46 |  |
| &nbsp;&nbsp;&nbsp;Tax amounts | **(7)** | (5) | **(15)** | (9) |  |
| &nbsp;&nbsp;&nbsp;Net losses after tax | $**26** | $20 | $**53** | $37 |  |
| Total net losses/(gains) reclassified, net of tax | $**21** | $26 | $**(14)** | $120 |  |

---

**Note 12 - Acquisitions and Divestitures**

***Acquisition of Siete***

On January 17, 2025, we acquired all of the outstanding equity interest in Siete, a Mexican-American foods business, for total consideration of $1.2 billion in cash.

We accounted for the transaction as a business combination in the first quarter of 2025. We recognized and measured the identifiable assets acquired and liabilities assumed at their estimated fair values on the date of acquisition, in our PFNA segment. The preliminary estimates of the fair value of the identifiable assets acquired and liabilities assumed in this transaction as of the acquisition date primarily include goodwill and other intangible assets of approximately $1.2 billion. These preliminary estimates include management's assumptions and are subject to revision as additional information is obtained about the facts and circumstances that existed as of the acquisition date, primarily related to intangible assets, which may result in adjustments to the preliminary values discussed above as valuations are finalized. We expect to finalize these amounts as soon as possible, but no later than the first quarter of 2026.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

***Acquisition of poppi***

On May 19, 2025, we acquired all of the outstanding equity interest in poppi, a prebiotic soda business, for cash consideration of $1.95 billion and contingent consideration with an acquisition date fair value of $0.2 billion. See Note 9 for further information on the contingent consideration. In connection with this acquisition, other payments may be incurred, subject to the achievement of certain conditions.

We accounted for the transaction as a business combination in the second quarter of 2025. We recognized and measured the identifiable assets acquired and liabilities assumed at their estimated fair values on the date of acquisition, in our PBNA segment. The preliminary estimates of the fair value of the identifiable assets acquired and liabilities assumed in this transaction as of the acquisition date primarily include goodwill and other intangible assets of approximately $2.0 billion. These preliminary estimates include management's assumptions and are subject to revision as additional information is obtained about the facts and circumstances that existed as of the acquisition date, primarily related to intangible assets, which may result in adjustments to the preliminary values discussed above as valuations are finalized. We expect to finalize these amounts as soon as possible, but no later than the second quarter of 2026.

***Acquisition and Divestiture-Related Charges***

Acquisition and divestiture-related charges primarily include transaction expenses, such as consulting, advisory and other professional fees, and merger and integration charges, as well as fair value adjustments to the acquired inventory included in the acquisition-date balance sheets. Merger and integration charges include distribution agreement termination fees, impairment of certain acquisition-related intangibles, employee-related costs, closing costs and other integration costs.

A summary of charges is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| Cost of sales | $**46** | $— | $**46** | $— |
| Selling, general and administrative expenses | **125** | 5 | **212** | 7 |
| Impairment of intangible assets | **50** |  | **50** |  |
| Total | $**221** | $5 | $**308** | $7 |
| After-tax amount | $**169** | $4 | $**236** | $5 |
| Impact on net income attributable to PepsiCo per common share | $**(0.12)** | $— | $**(0.17)** | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 | **9/6/2025** | 9/7/2024 |
| PFNA | $**2** | $— | $**23** | $— |
| PBNA | **219** | 5 | **285** | 7 |
| Total | $**221** | $5 | $**308** | $7 |

---

**Note 13 - Supply Chain Financing Arrangements**

We maintain voluntary supply chain finance agreements with several participating global financial institutions. Under these agreements, our suppliers, at their sole discretion, may elect to sell their accounts receivable with PepsiCo to these participating global financial institutions. As of both September 6, 2025 and December 28, 2024, $1.5 billion of our accounts payable are to suppliers participating in these financing arrangements. For further information on the key terms of these supply chain financing programs, see Note 14 to our consolidated financial statements in our Recast Segment Information.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Note 14 - Legal Contingencies**

The Company is party to a variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations. While the results of such litigation, claims, legal or regulatory proceedings, inquiries and investigations cannot be predicted with certainty, management believes that the final outcome of the foregoing is not expected to have a material adverse effect on our financial condition, results of operations or cash flows.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

**FINANCIAL REVIEW**

*Our discussion and analysis is intended to help the reader understand our results of operations and financial condition and is provided as an addition to, and should be read in connection with, our condensed consolidated financial statements and the accompanying notes. Unless otherwise noted, tabular dollars are presented in millions, except per share amounts. All per share amounts reflect common stock per share amounts, assume dilution unless otherwise noted, and are based on unrounded amounts. Percentage changes are based on unrounded amounts.*

**Our Critical Accounting Policies and Estimates**

The critical accounting policies and estimates below should be read in conjunction with those outlined in our Recast Segment Information.

***Total Marketplace Spending***

We offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue. A number of our sales incentives, such as bottler funding to independent bottlers and customer volume rebates, are based on annual targets, and accruals are established during the year, as products are delivered, for the expected payout, which may occur after year end once reconciled and settled.

These accruals are based on contract terms and our historical experience with similar programs and require management judgment with respect to estimating customer and consumer participation and performance levels. Differences between estimated expense and actual incentive costs are normally insignificant and are recognized in earnings in the period such differences are determined. In addition, certain advertising and marketing costs are also based on annual targets and recognized during the year as incurred.

For interim reporting, our policy is to allocate our forecasted full-year sales incentives for most of our programs to each of our interim reporting periods in the same year that benefits from the programs. The allocation methodology is based on our forecasted sales incentives for the full year and the proportion of each interim period's actual gross revenue or volume, as applicable, to our forecasted annual gross revenue or volume, as applicable. Based on our review of the forecasts at each interim period, any changes in estimates and the related allocation of sales incentives are recognized beginning in the interim period that they are identified. In addition, we apply a similar allocation methodology for interim reporting purposes for certain advertising and other marketing activities.

***Income Taxes***

In determining our quarterly provision for income taxes, we use an estimated annual effective tax rate which is based on our expected annual income, statutory tax rates and tax structure and transactions, including transfer pricing arrangements, available to us in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax rate and in evaluating our tax positions. Subsequent recognition, derecognition and measurement of a tax position taken in a previous period are separately recognized in the quarter in which they occur.

**Our Business Risks**

*This Form 10-Q contains statements reflecting our views about our future performance that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (Reform Act). Statements that constitute forward-looking statements within the meaning of the Reform Act* 

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

*are generally identified through the inclusion of words such as "aim," "anticipate," "believe," "drive," "estimate," "expect," "expressed confidence," "forecast," "future," "goal," "guidance," "intend," "may," "objective," "outlook," "plan," "position," "potential," "project," "seek," "should," "strategy," "target," "will" or similar statements or variations of such words and other similar expressions. All statements addressing our future operating performance, and statements addressing events and developments that we expect or anticipate will occur in the future, are forward-looking statements within the meaning of the Reform Act. These forward-looking statements are based on currently available information, operating plans and projections about future events and trends. They inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in any such forward-looking statement. Such risks and uncertainties include, but are not limited to: future demand for PepsiCo's products; damage to PepsiCo's reputation or brand image; product recalls or other issues or concerns with respect to product quality and safety; PepsiCo's ability to compete effectively; PepsiCo's ability to attract, develop and maintain a highly skilled workforce or effectively manage changes in our workforce; water scarcity; changes in the retail landscape or in sales to any key customer; disruption of PepsiCo's manufacturing operations or supply chain, including increased commodity, packaging, transportation, labor and other input costs; political, social or geopolitical conditions in the markets where PepsiCo's products are made, manufactured, distributed or sold; PepsiCo's ability to grow its business in developing and emerging markets; changes in economic conditions in the countries in which PepsiCo operates; changes in tariffs and global trade relations; future cyber incidents and other disruptions to our information systems; failure to successfully complete or manage strategic transactions; PepsiCo's reliance on third-party service providers and enterprise-wide systems; climate change or measures to address climate change and other sustainability matters; strikes or work stoppages; failure to realize benefits from PepsiCo's productivity initiatives or organizational restructurings; deterioration in estimates and underlying assumptions regarding future performance of our business or investments that can result in impairment charges; fluctuations or other changes in exchange rates; any downgrade or potential downgrade of PepsiCo's credit ratings; imposition or proposed imposition of new or increased taxes aimed at PepsiCo's products; imposition of limitations on the marketing or sale of PepsiCo's products; changes in laws and regulations related to the use or disposal of plastics or other packaging materials; failure to comply with personal data protection and privacy laws; increase in income tax rates, changes in income tax laws or disagreements with tax authorities; failure to adequately protect PepsiCo's intellectual property rights or infringement on intellectual property rights of others; failure to comply with applicable laws and regulations; potential liabilities and costs from litigation, claims, legal or regulatory proceedings, inquiries or investigations; and other risks and uncertainties including those described in "Item 1A. Risk Factors" in our 2024 Form 10-K, "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks," included in our Recast Segment Information and in "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks" of this Form 10-Q. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.*

***Risks Associated with Commodities and Our Supply Chain***

Many of the commodities used in the production and transportation of our products are purchased in the open market. The prices we pay for such items are subject to fluctuation, and we manage this risk through the use of fixed-price contracts and purchase orders, pricing agreements and derivative instruments, including swaps and futures. A number of external factors, including volatile geopolitical conditions, the inflationary cost environment, import/export restrictions and tariffs, adverse weather conditions and supply chain disruptions, have impacted and may continue to impact commodity, transportation and labor

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

costs. When prices increase, we may or may not pass on such increases to our customers, which may result in reduced volume, revenue, margins and operating results.

See Note 9 to our condensed consolidated financial statements in this Form 10-Q and Note 9 to our consolidated financial statements in our Recast Segment Information for further information on how we manage our exposure to commodity prices.

***Risks Associated with Climate Change***

Certain jurisdictions in which our products are made, manufactured, distributed or sold have either imposed, or are considering imposing, new or increased legal and regulatory requirements to reduce or mitigate the potential effects of climate change, including regulation of greenhouse gas emissions and potential carbon pricing programs. These new or increased legal or regulatory requirements, along with initiatives to meet our sustainability goals, could result in significant increased costs and additional investments in facilities and equipment. However, we are unable to predict the scope, nature and timing of any new or increased environmental laws and regulations and therefore cannot predict the ultimate impact of such laws and regulations on our business or financial results. We continue to monitor existing and proposed laws and regulations in the jurisdictions in which our products are made, manufactured, distributed and sold and to consider actions we may take to potentially mitigate the unfavorable impact, if any, of such laws or regulations.

***Risks Associated with International Operations***

In the 12 weeks ended September 6, 2025, our financial results outside of North America reflect the months of June, July and August. In the 36 weeks ended September 6, 2025, our financial results outside of North America reflect the months of January through August. In the 36 weeks ended September 6, 2025, our operations outside of the United States generated 43% of our consolidated net revenue, with Mexico, Russia, Canada, China, the United Kingdom, Brazil and South Africa comprising approximately 24% of our consolidated net revenue. As a result, we are exposed to foreign exchange risk in the international markets in which our products are made, manufactured, distributed or sold. In the 12 weeks ended September 6, 2025, favorable foreign exchange contributed to net revenue performance by 0.5 percentage points primarily driven by an appreciation of the Russian ruble, euro, British pound and Polish zloty, partially offset by declines in the Turkish lira, Mexican peso and Argentine peso. In the 36 weeks ended September 6, 2025, unfavorable foreign exchange reduced net revenue performance by 1 percentage point primarily driven by declines in the Mexican peso, Turkish lira, Egyptian pound and Brazilian real, partially offset by an appreciation of the Russian ruble. Currency declines against the U.S. dollar which are not offset could adversely impact our future financial results.

In addition, volatile economic, political, social and geopolitical conditions, civil unrest and wars and other military conflicts, acts of terrorism and natural disasters and other catastrophic events in certain markets in which our products are made, manufactured, distributed or sold, including in Argentina, Brazil, China, Mexico, the Middle East (including Egypt), Russia, Turkey and Ukraine, continue to result in challenging operating environments and have resulted in and could continue to result in changes in how we operate in certain of these markets. Debt and credit issues, currency controls or fluctuations, sanctions and export controls in certain of these international markets (including restrictions on the transfer of funds to and from certain markets) have also continued to impact our operations in certain of these international markets. We continue to closely monitor the economic, operating and political environment in the markets in which we operate, including risks of additional impairments or write-offs and currency fluctuation, and to identify actions to potentially mitigate any unfavorable impacts on our future results. Our operations in Russia accounted for 5.5% and 5% of our consolidated net revenue for the 12 and 36 weeks ended September 6, 2025, respectively. Russia accounted for 4.5% of our consolidated assets, including 15% of

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

our consolidated cash and cash equivalents and 39% of our accumulated currency translation adjustment loss as of September 6, 2025.

See Note 9 to our condensed consolidated financial statements in this Form 10-Q for the fair values of our financial instruments as of September 6, 2025 and December 28, 2024 and Note 9 to our consolidated financial statements in our Recast Segment Information for a discussion of these items.

***Risks Associated with Tariffs***

The imposition of tariffs (including U.S. tariffs imposed or threatened to be imposed on China, the European Union, Canada and Mexico and other countries and any tariffs imposed by such countries) have impacted and could continue to impact our supply chain resulting in increased input costs, including the cost of certain raw materials and packaging. The impact of tariffs will continue to vary, including based on where inputs are sourced from and shipped to. In addition, any supply chain constraints, inflationary impacts or reduced consumer demand for our products as a result of such tariffs or ongoing macroeconomic uncertainty have impacted and could continue to impact our results. We will continue to evaluate the nature and extent of the impact of these tariffs on our business and to identify actions to potentially mitigate, where possible, any unfavorable impacts on our future results.

***Imposition of Taxes and Regulations on our Products***

Certain jurisdictions in which our products are made, manufactured, distributed or sold have either imposed, or are considering imposing, new or increased taxes or regulations on the manufacture, distribution or sale of our products or their packaging, ingredients or substances contained in, or attributes of, our products or their packaging, commodities used in the production of our products or their packaging or the recyclability or recoverability of our packaging. These taxes and regulations vary in scope and form. For example, some taxes apply to all beverages, including non-caloric beverages, while others apply only to beverages with a caloric sweetener (e.g., sugar). Further, some regulations apply to all products using certain types of packaging (e.g., plastic), while others are designed to increase the sustainability of packaging, encourage waste reduction and increased recycling rates or facilitate the waste management process or restrict the sale of products in certain packaging. In addition, certain jurisdictions in which our snack products are sold have either imposed or are considering imposing, new or increased taxes on the manufacture, distribution or sale of certain of our snack products as a result of ingredients (such as sugar, sodium or saturated fat) contained in our products.

We sell a wide variety of beverages and convenient foods in more than 200 countries and territories and the profile of the products we sell, the amount of revenue attributable to such products and the type of packaging used vary by jurisdiction. Because of this, we cannot predict the scope or form potential taxes, regulations or other limitations on our products or their packaging may take, and therefore cannot predict the impact of such taxes, regulations or limitations on our financial results. In addition, taxes, regulations and limitations may impact us and our competitors differently. We expect continued scrutiny of certain ingredients and substances present in certain of our products and packaging. We continue to monitor existing and proposed taxes and regulations in the jurisdictions in which our products are made, manufactured, distributed and sold and to consider actions we may take to potentially mitigate the unfavorable impact, if any, of such taxes, regulations or limitations, including advocating alternative measures with respect to the imposition, form and scope of any such taxes, regulations or limitations.

***OECD Global Minimum Tax***

Numerous countries, including European Union member states, have enacted, or are expected to enact, legislation incorporating the OECD model rules for a global minimum tax rate of 15%. Widespread implementation is expected by the end of 2025, with certain countries that have not yet enacted potentially applying the legislation as of a retroactive date. As the legislation becomes effective in countries in which

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

we do business, our taxes could increase and negatively impact our provision for income taxes. We will continue to monitor pending legislation and implementation by individual countries and evaluate the potential impact on our business in future periods.

***Retail Landscape***

Our industry continues to be affected by disruption of the retail landscape, including the continued growth in sales through e-commerce websites and mobile commerce applications, including through subscription services, the integration of physical and digital operations among retailers and the international expansion of hard discounters. We have seen and expect to continue to see a further shift to e-commerce, online-to-offline and other online purchasing by consumers. We continue to monitor changes in the retail landscape and seek to identify actions we may take to build our global e-commerce and digital capabilities, such as expanding our direct-to-consumer business, and distribute our products effectively through all existing and emerging channels of trade and potentially mitigate any unfavorable impacts on our future results.

The retail industry also continues to be impacted by the actions and increasing power of retailers, including as a result consolidation of ownership resulting in large retailers or buying groups with increased purchasing power, particularly in North America, Europe and Latin America. We have seen and expect to continue to see retailers and buying groups impact our ability to compete in these jurisdictions. We continue to monitor our relationships with retailers and buying groups and seek to identify actions we may take to maintain mutually beneficial relationships and resolve any significant disputes and potentially mitigate any unfavorable impacts on our future results.

Cautionary statements included above and in "Item 1A. Risk Factors" in our 2024 Form 10-K and "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks" in our Recast Segment Information should be considered when evaluating our trends and future results.

**Results of Operations – Consolidated Review**

***Consolidated Results***

***Volume***

Physical or unit volume is one of the key metrics management uses internally to make operating and strategic decisions, including the preparation of our annual operating plan and the evaluation of our business performance. We believe volume provides additional information to facilitate the comparison of our historical operating performance and underlying trends and provides additional transparency on how we evaluate our business because it measures demand for our products at the consumer level. See "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Our Financial Results – Volume" included in our Recast Segment Information for further information on volume. Unit volume performance adjusts for the impacts of acquisitions and divestitures. Acquisitions and divestitures, when used in this report, reflect mergers and acquisitions activity, as well as divestitures and other structural changes, including changes in ownership or control in consolidated subsidiaries and nonconsolidated equity investees. Further, unit volume performance excludes the impact of an additional week of results every five or six years (53<sup>rd</sup> reporting week), where applicable.

We report all of our international operations on a monthly calendar basis. The 12 weeks ended September 6, 2025 and September 7, 2024 include volume outside of North America for the months of June, July and August. The 36 weeks ended September 6, 2025 and September 7, 2024 include volume outside of North America for the months of January through August.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

***Consolidated Net Revenue and Operating Profit***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
|  | **9/6/2025** | 9/7/2024 | **Change** | **9/6/2025** | 9/7/2024 | **Change** |
| Net revenue | $**23937** | $23319 | **3%** | $**64582** | $64070 | **1%** |
| Operating profit | $**3569** | $3872 | **(8)%** | $**7941** | $10637 | **(25)%** |
| Operating margin | **14.9%** | 16.6% | **(1.7)** | **12.3%** | 16.6% | **(4.3)** |

---

See "Results of Operations – Segment Review" for a tabular presentation and discussion of key drivers of net revenue.

**12 Weeks** 

Operating profit decreased 8% and operating margin declined 1.7 percentage points. Operating profit performance was primarily driven by certain operating cost increases, a decline in organic volume, an 8-percentage-point impact of higher commodity costs, partly driven by a 3-percentage-point impact of tariffs, and higher acquisition and divestiture-related charges. These impacts were partially offset by productivity savings, effective net pricing and lower advertising and marketing expenses. The operating margin decline primarily reflects the acquisition and divestiture-related charges related to our poppi acquisition.

**36 Weeks**

Operating profit decreased 25% and operating margin declined 4.3 percentage points. Operating profit performance was primarily driven by certain operating cost increases, impairment charges related to the Rockstar brand, a decline in organic volume and a 5.5-percentage-point impact of higher commodity costs. These impacts were partially offset by productivity savings, effective net pricing and lower advertising and marketing expenses. The operating margin decline primarily reflects the unfavorable impact of the impairment charges related to the Rockstar brand.

***Other Consolidated Results***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 | **Change** | **9/6/2025** | 9/7/2024 | **Change** |
| Other pension and retiree medical benefits income | $**26** | $41 | $**(15)** | $**91** | $155 | $**(64)** |
| Net interest expense and other | $**264** | $219 | $**45** | $**788** | $655 | $**133** |
| Tax rate | **21.4%** | 20.3% |  | **20.8%** | 20.2% |  |
| Net income attributable to PepsiCo | $**2603** | $2930 | **(11)%** | $**5700** | $8055 | **(29)%** |
| Net income attributable to PepsiCo per common share – diluted  | $**1.90** | $2.13 | **(11)%** | $**4.15** | $5.84 | **(29)%** |

---

**12 Weeks**

Other pension and retiree medical benefits income decreased $15 million, primarily reflecting recognition of fixed income losses on plan assets and the impact of certain plan changes approved in 2020, as discussed in Note 7 to our consolidated financial statements in our Recast Segment Information, partially offset by higher prior-year recognition of special termination benefits due to restructuring actions as part of our 2019 Productivity Plan.

Net interest expense and other increased $45 million, due to higher average debt balances, higher interest rates on average debt balances and lower interest rates on average cash balances, partially offset by higher average cash balances and higher gains on the market value of investments used to economically hedge a portion of our deferred compensation liability.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

The reported tax rate increased 1.1 percentage points, primarily reflecting the unfavorable impact of a tax audit settlement in our LatAm Foods segment, partially offset by the reversal of deferred tax liability on undistributed earnings as a result of a tax election.

**36 Weeks**

Other pension and retiree medical benefits income decreased $64 million, primarily reflecting recognition of fixed income losses on plan assets and the impact of certain plan changes approved in 2020, as discussed in Note 7 to our consolidated financial statements in our Recast Segment Information, partially offset by higher prior-year recognition of special termination benefits due to restructuring actions as part of our 2019 Productivity Plan.

Net interest expense and other increased $133 million, primarily due to higher average debt balances, higher interest rates on average debt balances and lower interest rates on average cash balances, partially offset by higher average cash balances.

The reported tax rate increased 0.6 percentage points, primarily reflecting the impact of a prior-year release of a valuation allowance in a foreign jurisdiction.

**Results of Operations – Segment Review**

Effective beginning with our first quarter of 2025, we realigned certain of our reportable segments to conform with changes to our organizational structure and how our Chief Executive Officer regularly reviews the performance of, and allocates resources to, these segments. Our historical segment reporting has been recast to reflect our current organizational structure.

While our financial results in North America are reported on a 12-week basis, all of our international operations are reported on a monthly calendar basis for which the months of June, July and August are reflected in our results for the 12 weeks ended September 6, 2025 and September 7, 2024, and the months January through August are reflected in our results for the 36 weeks ended September 6, 2025 and September 7, 2024.

In the discussions of net revenue and operating profit below, "effective net pricing" reflects the year-over-year impact of discrete pricing actions, sales incentive activities and mix resulting from selling varying products in different package sizes and in different countries.

See "Our Business Risks," "Non-GAAP Measures" and "Items Affecting Comparability" for a discussion of items to consider when evaluating our results and related information regarding measures not in accordance with GAAP.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

***Net Revenue and Organic Revenue Performance***

Organic revenue performance is a non-GAAP financial measure. For a description of and further information regarding this measure, see "Non-GAAP Measures."

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** |
| | | **Impact of** | **Impact of** | | **Impact of** | **Impact of** |
| |<br>**Reported % Change, GAAP measure** | **Foreign exchange translation** | **Acquisitions and divestitures** |<br>**Organic** <br>**% Change, non-GAAP measure**<sup>(a)</sup> | **Organic volume change**<sup>(b)</sup> | **Effective net pricing** |
| PFNA | **— %** |  | (2.5) | **(3)%** | (4) | 2 |
| PBNA | **2%** |  |  | **2%** | (4) | 6 |
| IB Franchise | **— %** | (1) |  | **(1)%** | (5) | 4 |
| EMEA | **9%** | (4) |  | **5.5%** |  | 6 |
| LatAm Foods | **2%** | 2 |  | **4%** |  | 4 |
| Asia Pacific Foods | **2%** |  | (1) | **1%** | 4 | (3) |
| Total | **3%** | (0.5) | (1) | **1%** | (3) | 4 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** |
| | | **Impact of** | **Impact of** | | **Impact of** | **Impact of** |
| |<br>**Reported % Change, GAAP measure** | **Foreign exchange translation** | **Acquisitions and divestitures** |<br>**Organic** <br>**% Change, non-GAAP measure**<sup>(a)</sup> | **Organic volume change**<sup>(b)</sup> | **Effective net pricing** |
| PFNA | **— %** |  | (2) | **(2)%** | (3) | 1 |
| PBNA | **1%** |  |  | **1%** | (3) | 4 |
| IB Franchise | **2%** | 1 |  | **3%** |  | 3 |
| EMEA | **6%** |  |  | **6%** | (3.5) | 10 |
| LatAm Foods | **(5)%** | 10 |  | **4%** | 1 | 3 |
| Asia Pacific Foods | **— %** | 1 | (1) | **— %** | 5 | (4.5) |
| Total | **1%** | 1 | (0.5) | **1.5%** | (2) | 4 |

---

(a)Amounts may not sum due to rounding.

(b)Excludes the impact of acquisitions and divestitures. In certain instances, the impact of organic volume change on net revenue performance differs from the unit volume change disclosed in the following segment discussions due to the impacts of product mix, nonconsolidated joint venture volume, and, for our franchise beverage businesses, temporary timing differences between bottler case sales and concentrate shipments and equivalents (CSE). We report net revenue from our franchise beverage businesses based on CSE. The volume sold by our nonconsolidated joint ventures has no direct impact on our net revenue.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

***Operating Profit, Operating Profit Adjusted for Items Affecting Comparability and Operating Profit Performance Adjusted for Items Affecting Comparability on a Constant Currency Basis***

Operating profit adjusted for items affecting comparability and operating profit performance adjusted for items affecting comparability on a constant currency basis are both non-GAAP financial measures. For a description of and further information regarding these measures, see "Non-GAAP Measures" and "Items Affecting Comparability."

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** |
| | **PFNA** | **PBNA** | **IB Franchise** | **EMEA** | **LatAm Foods** | **Asia Pacific Foods** | **Corporate unallocated expenses** | **Total** |
| Reported, GAAP measure | $1536 | $729 | $436 | $720 | $424 | $151 | $(427) | $3569 |
| Items Affecting Comparability <sup>(a)</sup> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Mark-to-market net impact |  |  |  |  |  |  | 23 | 23 |
| &nbsp;&nbsp;Restructuring and impairment charges | 32 | 19 | 2 | 69 | 17 | 5 | (2) | 142 |
| &nbsp;&nbsp;Acquisition and divestiture-related charges | 2 | 219 |  |  |  |  |  | 221 |
| &nbsp;&nbsp;Impairment and other charges |  | 8 | 73 | 19 |  |  |  | 100 |
| &nbsp;&nbsp;Indirect and income tax impact |  |  |  |  | 82 |  |  | 82 |
| Core, non-GAAP measure | 1570 | 975 | 511 | 808 | 523 | 156 | (406) | 4137 |
| Impact of foreign exchange translation |  |  | (3) | (30) | 11 | (1) |  | (23) |
| Core Constant Currency, non-GAAP measure | $1570 | $975 | $508 | $778 | $534 | $155 | $(406) | $4114 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Reported Operating Profit % Change, GAAP measure | (5)% | (20)% | (5)% | 1% | (12)% | 16% | (3.5)% | (8)% |
| Core Operating Profit % Change, non-GAAP measure | (3.5)% | (7)% | 8% | 7% | 6% | 19% | 16% | (1)% |
| Core Constant Currency Operating Profit % Change, non-GAAP measure | (3.5)% | (7)% | 7% | 3% | 9% | 18% | 16% | (1.5)% |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 |
| | PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Corporate unallocated expenses | Total |
| Reported, GAAP measure | $1620 | $914 | $458 | $713 | $480 | $129 | $(442) | $3872 |
| Items Affecting Comparability <sup>(a)</sup> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Mark-to-market net impact |  |  |  |  |  |  | 52 | 52 |
| &nbsp;&nbsp;Restructuring and impairment charges | 8 | 128 | 15 | 35 | 11 | 2 | 39 | 238 |
| &nbsp;&nbsp;Acquisition and divestiture-related charges |  | 5 |  |  |  |  |  | 5 |
| &nbsp;&nbsp;Impairment and other charges/credits |  |  |  | 10 |  |  |  | 10 |
| &nbsp;&nbsp;Product recall-related impact | (1) |  |  |  |  |  |  | (1) |
| Core, non-GAAP measure | $1627 | $1047 | $473 | $758 | $491 | $131 | $(351) | $4176 |

---

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** |
| | **PFNA** | **PBNA** | **IB Franchise** | **EMEA** | **LatAm Foods** | **Asia Pacific Foods** | **Corporate unallocated expenses** | **Total** |
| Reported, GAAP measure | $4463 | $550 | $1248 | $1310 | $1301 | $321 | $(1252) | $7941 |
| Items Affecting Comparability <sup>(a)</sup> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Mark-to-market net impact |  |  |  |  |  |  | (8) | (8) |
| &nbsp;&nbsp;Restructuring and impairment charges | 147 | 192 | 7 | 118 | 36 | 9 | 45 | 554 |
| &nbsp;&nbsp;Acquisition and divestiture-related charges | 23 | 285 |  |  |  |  |  | 308 |
| &nbsp;&nbsp;Impairment and other charges |  | 1537 | 73 | 270 |  | 80 |  | 1960 |
| &nbsp;&nbsp;Indirect and income tax impact |  |  |  |  | 82 |  |  | 82 |
| Core, non-GAAP measure | 4633 | 2564 | 1328 | 1698 | 1419 | 410 | (1215) | 10837 |
| Impact of foreign exchange translation | 6 | 4 | 20 | (16) | 170 | 2 |  | 186 |
| Core Constant Currency, non-GAAP measure | $4639 | $2568 | $1348 | $1682 | $1589 | $412 | $(1215) | $11023 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Reported Operating Profit % Change, GAAP measure | (7)% | (77)% | 2% | (13)% | (9)% | (21)% | 9% | (25)% |
| Core Operating Profit % Change, non-GAAP measure | (8)% | —% | 7% | 7% | (3)% | (1)% | 14% | (4)% |
| Core Constant Currency Operating Profit % Change, non-GAAP measure | (8)% | —% | 9% | 5.5% | 8% | —% | 14% | (2)% |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 |
| | PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Corporate unallocated expenses | Total |
| Reported, GAAP measure | $4802 | $2411 | $1221 | $1509 | $1436 | $407 | $(1149) | $10637 |
| Items Affecting Comparability <sup>(a)</sup> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Mark-to-market net impact |  |  |  |  |  |  | 8 | 8 |
| &nbsp;&nbsp;Restructuring and impairment charges | 47 | 143 | 15 | 75 | 32 | 6 | 75 | 393 |
| &nbsp;&nbsp;Acquisition and divestiture-related charges |  | 7 |  |  |  |  |  | 7 |
| &nbsp;&nbsp;Impairment and other charges |  |  |  | 10 |  |  |  | 10 |
| &nbsp;&nbsp;Product recall-related impact | 181 |  |  |  |  |  |  | 181 |
| Core, non-GAAP measure | $5030 | $2561 | $1236 | $1594 | $1468 | $413 | $(1066) | $11236 |

---

(a)See "Items Affecting Comparability" for further information.

**PFNA**

***12 Weeks***

Net revenue decreased slightly, primarily driven by a decrease in organic volume, partially offset by the favorable impact of acquisitions and effective net pricing.

Unit volume declined 4%, driven by a 4% decrease in savory snacks volume and a 2% decrease in other foods volume.

Operating profit decreased 5%, primarily reflecting certain operating cost increases, including strategic initiatives, and the decrease in organic volume. These impacts were partially offset by productivity savings and a 4-percentage-point impact of gains on asset sales.

***36 Weeks***

Net revenue decreased slightly, primarily reflecting a decrease in organic volume, partially offset by the favorable impact of acquisitions.

Unit volume declined 2%, driven by a 3% decrease in savory snacks volume, partially offset by a 3.5% increase in other foods volume.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

Operating profit decreased 7%, primarily reflecting certain operating cost increases, including strategic initiatives, and the decrease in organic volume. These impacts were partially offset by productivity savings and a 3-percentage-point impact of gains on asset sales.

**PBNA**

***12 Weeks***

Net revenue increased 2%, primarily driven by effective net pricing, partially offset by an organic volume decline.

Unit volume declined 3%, driven by a 6% decline in non-carbonated beverage (NCB) volume, while carbonated soft drink (CSD) volume was even with the prior year.

Operating profit decreased 20%, primarily due to acquisition and divestiture-related charges related to our poppi acquisition, certain operating cost increases, a 13-percentage-point impact of higher commodity costs, largely driven by a 12-percentage-point impact of tariffs, and the decline in organic volume. These impacts were partially offset by productivity savings, lower restructuring charges, lower advertising and marketing expenses and the effective net pricing.

***36 Weeks***

Net revenue increased 1%, primarily driven by effective net pricing, partially offset by an organic volume decline.

Unit volume declined 3%, driven by a 6% decline in NCB volume, while CSD volume was even with the prior year.

Operating profit decreased 77%, primarily reflecting impairment charges related to the Rockstar brand. Operating profit also decreased due to certain operating cost increases, the decline in organic volume, acquisition and divestiture-related charges related to our poppi acquisition and a 5-percentage-point impact of higher commodity costs, driven by a 5-percentage-point impact of tariffs. These impacts were partially offset by productivity savings, the effective net pricing and lower advertising and marketing expenses.

**IB Franchise**

***12 Weeks***

Net revenue increased slightly, primarily reflecting effective net pricing and a 1-percentage-point impact of favorable foreign exchange translation, partially offset by an organic volume decline.

Unit volume declined 1%, primarily reflecting declines in Mexico and India, partially offset by growth in the Middle East.

Operating profit decreased 5%, primarily reflecting an impairment charge related to the Rockstar brand and a 4-percentage-point impact of higher commodity costs, partially offset by lower advertising and marketing costs and productivity savings.

***36 Weeks***

Net revenue increased 2%, primarily reflecting effective net pricing, partially offset by a 1-percentage-point impact of unfavorable foreign exchange translation.

Unit volume grew 1%, primarily reflecting growth in the Middle East, China and Pakistan, partially offset by a decline in Mexico.

Operating profit increased 2%, primarily reflecting the net revenue growth and lower advertising and marketing costs, partially offset by an impairment charge related to the Rockstar brand.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**EMEA**

***12 Weeks***

Net revenue increased 9%, primarily reflecting effective net pricing, part of which is from subsidiaries operating in highly inflationary economies, and a 4-percentage-point impact of favorable foreign exchange translation.

Convenient foods unit volume declined 1%, primarily reflecting declines in Russia, South Africa and the United Kingdom, partially offset by growth in the Middle East and Pakistan.

Beverage unit volume grew 1.5%, primarily reflecting growth in the Middle East, partially offset by declines in Turkey and Russia.

Operating profit increased 1%, primarily reflecting the effective net pricing, productivity savings, lower advertising and marketing costs and a 4-percentage-point impact of favorable foreign exchange translation. These impacts were partially offset by certain operating cost increases, an 18-percentage-point impact of higher commodity costs, primarily dairy, potatoes and cooking oil, and higher restructuring charges.

***36 Weeks***

Net revenue increased 6%, primarily reflecting effective net pricing, partially offset by an organic volume decline.

Convenient foods unit volume declined 5%, primarily reflecting declines in South Africa and Russia.

Beverage unit volume grew slightly, primarily reflecting growth in the Middle East, Germany, Poland, Turkey and France, partially offset by declines in South Africa and Russia.

Operating profit decreased 13%, primarily reflecting certain operating cost increases, a 24-percentage-point impact of higher commodity costs, primarily dairy, potatoes and cooking oil, and an impairment charge related to the Rockstar brand. These impacts were partially offset by the effective net pricing and productivity savings.

**LatAm Foods**

***12 Weeks***

Net revenue increased 2%, primarily reflecting effective net pricing, partially offset by a 2-percentage-point impact of unfavorable foreign exchange translation.

Unit volume declined slightly, primarily reflecting a decline in Mexico, partially offset by growth in Colombia and Brazil.

Operating profit decreased 12%, primarily reflecting certain operating cost increases, an unfavorable impact of an indirect tax audit settlement, and an 8-percentage-point impact of higher commodity costs, partially offset by productivity savings and the effective net pricing.

***36 Weeks***

Net revenue decreased 5%, primarily reflecting a 10-percentage-point impact of unfavorable foreign exchange translation, driven by the weakening of the Mexican peso, partially offset by effective net pricing.

Unit volume grew 1%, primarily reflecting growth in Brazil, Peru and Argentina, partially offset by a decline in Mexico.

Operating profit decreased 9%, primarily reflecting certain operating cost increases, a 12-percentage-point impact of unfavorable foreign exchange translation, driven primarily by the weakening of the Mexican

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

peso, a 7-percentage-point impact of higher commodity costs and an unfavorable impact of an indirect tax audit settlement, partially offset by productivity savings, the effective net pricing and a 4-percentage-point favorable impact of certain indirect tax credits in Brazil.

**Asia Pacific Foods**

***12 Weeks***

Net revenue increased 2%, primarily reflecting organic volume growth, partially offset by unfavorable net pricing.

Unit volume grew 3%, primarily reflecting growth in India, Australia and Thailand, partially offset by a decline in China.

Operating profit increased 16%, primarily reflecting productivity savings, lower advertising and marketing costs, the organic volume growth and a 5-percentage-point impact of lower commodity costs. These impacts were partially offset by certain operating cost increases and the unfavorable net pricing.

***36 Weeks***

Net revenue increased slightly, primarily reflecting organic volume growth, partially offset by unfavorable net pricing.

Unit volume grew 4%, primarily reflecting growth in India, Thailand and Australia.

Operating profit decreased 21%, primarily reflecting certain operating cost increases, the unfavorable net pricing and an impairment charge related to the Be & Cheery brand. These impacts were partially offset by productivity savings, lower advertising and marketing costs and the organic volume growth.

***Non-GAAP Measures***

Certain financial measures contained in this Form 10-Q adjust for the impact of specified items and are not in accordance with GAAP. We use non-GAAP financial measures internally to make operating and strategic decisions, including the preparation of our annual operating plan, evaluation of our overall business performance and as a factor in determining compensation for certain employees. We believe presenting non-GAAP financial measures in this Form 10-Q provides additional information to facilitate comparison of our historical operating results and trends in our underlying operating results and provides additional transparency on how we evaluate our business. We also believe presenting these measures in this Form 10-Q allows investors to view our performance using the same measures that we use in evaluating our financial and business performance and trends.

We consider quantitative and qualitative factors in assessing whether to adjust for the impact of items that may be significant or that could affect an understanding of our ongoing financial and business performance or trends. Examples of items for which we may make adjustments include: amounts related to mark-to-market gains or losses (non-cash); charges related to restructuring plans; charges associated with acquisitions and divestitures; gains associated with divestitures; asset impairment charges (non-cash); product recall-related impact; pension and retiree medical-related amounts, including all settlement and curtailment gains and losses; charges or adjustments related to the enactment of new laws, rules or regulations, such as tax law changes; amounts related to the resolution of tax positions; tax benefits related to reorganizations of our operations; debt redemptions, cash tender or exchange offers; and remeasurements of net monetary assets. See below and "Items Affecting Comparability" for a description of adjustments to our GAAP financial measures in this Form 10-Q.

Non-GAAP information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

addition, our non-GAAP financial measures may not be the same as or comparable to similar non-GAAP measures presented by other companies.

The following non-GAAP financial measures contained in this Form 10-Q are discussed below:

*Organic revenue performance*

We define organic revenue performance as a measure that adjusts for the impacts of foreign exchange translation (on a constant currency basis, as defined below), acquisitions and divestitures, and where applicable, the impact of the 53<sup>rd</sup> reporting week. Beginning with our first quarter of 2025, on a prospective basis, we are also applying the constant currency calculation for our subsidiaries operating in highly inflationary economies. We believe organic revenue performance provides useful information in evaluating the results of our business because it adjusts for items that we believe are not indicative of ongoing performance or that we believe impact comparability with the prior year.

See "Net Revenue and Organic Revenue Performance" in "Results of Operations – Segment Review" for further information.

*Cost of sales, gross profit, selling, general and administrative expenses, impairment of intangible assets, other pension and retiree medical benefits income, provision for income taxes, net income attributable to noncontrolling interests and net income attributable to PepsiCo, each adjusted for items affecting comparability, operating profit and net income attributable to PepsiCo per common share – diluted, each adjusted for items affecting comparability and the corresponding constant currency growth rates*

These measures exclude the net impact of mark-to-market gains and losses on centrally managed commodity derivatives that do not qualify for hedge accounting, restructuring and impairment charges related to our 2019 Productivity Plan, charges associated with our acquisitions and divestitures, impairment and other charges, indirect and income tax impact, product recall-related impact and the impact of settlement and curtailment gains and losses related to pension and retiree medical plans (see "Items Affecting Comparability" for a detailed description of each of these items). We also evaluate performance on operating profit and net income attributable to PepsiCo per common share – diluted, each adjusted for items affecting comparability on a constant currency basis, which measure our financial results assuming constant foreign currency exchange rates used for translation based on the rates in effect for the comparable prior-year period. In order to compute our constant currency results, we multiply or divide, as appropriate, our current-year U.S. dollar results by the current-year average foreign exchange rates and then multiply or divide, as appropriate, those amounts by the prior-year average foreign exchange rates. In addition, beginning with our first quarter of 2025, on a prospective basis, we are also applying the constant currency calculation for our subsidiaries operating in highly inflationary economies. We believe these measures provide useful information in evaluating the results of our business because they exclude items that we believe are not indicative of our ongoing performance or that we believe impact comparability with the prior year.

*Free cash flow*

We define free cash flow as net cash from operating activities less capital spending, plus sales of property, plant and equipment. Since net capital spending is essential to our product innovation initiatives and maintaining our operational capabilities, we believe that it is a recurring and necessary use of cash. As such, we believe investors should also consider net capital spending when evaluating our cash from operating activities. Free cash flow is used by us primarily for acquisitions and financing activities, including debt repayments, dividends and share repurchases. Free cash flow is not a measure of cash available for discretionary expenditures since we have certain non-discretionary obligations such as debt service that are not deducted from the measure.

See "Free Cash Flow" in "Our Liquidity and Capital Resources" for further information.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

***Items Affecting Comparability***

Our reported financial results in this Form 10-Q are impacted by the following items in each of the following periods:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** | **12 Weeks Ended 9/6/2025** |
| | **Cost of sales** | **Gross profit** | **Selling, general and administrative expenses** | **Impairment of intangible assets** | **Operating profit** | **Other pension and retiree medical benefits income** | **Provision**<br>**for income taxes**<sup>(a)</sup> | **Net income attributable to PepsiCo** |
| Reported, GAAP measure | $**11113** | $**12824** | $**9122** | $**133** | $**3569** | $**26** | $**713** | $**2603** |
| Items Affecting Comparability |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market net impact | (18) | 18 | (5) |  | 23 |  | 6 | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and impairment charges | (16) | 16 | (126) |  | 142 | (1) | 25 | 116 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and divestiture-related charges | (46) | 46 | (125) | (50) | 221 |  | 52 | 169 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment and other charges |  |  | (17) | (83) | 100 |  | 8 | 92 |
| &nbsp;&nbsp;&nbsp;&nbsp;Indirect and income tax impact <sup>(b)</sup> |  |  | (82) |  | 82 |  | (47) | 129 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and retiree medical-related impact |  |  |  |  |  | 13 | 2 | 11 |
| Core, non-GAAP measure | $**11033** | $**12904** | $**8767** | $**—** | $**4137** | $**38** | $**759** | $**3137** |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 | 12 Weeks Ended 9/7/2024 |
| | Cost of sales | Gross profit | Selling, general and administrative expenses | Impairment of intangible assets | Operating profit | Other pension and retiree medical benefits income | Provision for income taxes<sup>(a)</sup> | Net income attributable to noncontrolling interests | Net income attributable to PepsiCo |
| Reported, GAAP measure | $10396 | $12923 | $9027 | $24 | $3872 | $41 | $749 | $15 | $2930 |
| Items Affecting Comparability |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market net impact | (19) | 19 | (33) |  | 52 |  | 12 |  | 40 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and impairment charges | (10) | 10 | (214) | (14) | 238 | 7 | 50 | 2 | 193 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and divestiture-related charges |  |  | (5) |  | 5 |  | 1 |  | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment and other charges |  |  |  | (10) | 10 |  | 2 |  | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product recall-related impact | 1 | (1) |  |  | (1) | 3 |  |  | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and retiree medical-related impact |  |  |  |  |  | 15 | 3 |  | 12 |
| Core, non-GAAP measure | $10368 | $12951 | $8775 | $— | $4176 | $66 | $817 | $17 | $3189 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** | **36 Weeks Ended 9/6/2025** |
| | **Cost of sales** | **Gross profit** | **Selling, general and administrative expenses** | **Impairment of intangible assets** | **Operating profit** | **Other pension and retiree medical benefits** **income** | **Provision**<br>**for income taxes**<sup>(a)</sup> | **Net income attributable to PepsiCo** |
| Reported, GAAP measure | $**29343** | $**35239** | $**25305** | $**1993** | $**7941** | $**91** | $**1504** | $**5700** |
| Items Affecting Comparability |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market net impact | (9) | 9 | 17 |  | (8) |  | (2) | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and impairment charges | (119) | 119 | (435) |  | 554 | 13 | 100 | 467 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and divestiture-related charges | (46) | 46 | (212) | (50) | 308 |  | 72 | 236 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment and other charges |  |  | (17) | (1943) | 1960 |  | 421 | 1539 |
| &nbsp;&nbsp;&nbsp;&nbsp;Indirect and income tax impact <sup>(b)</sup> |  |  | (82) |  | 82 |  | (47) | 129 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and retiree medical-related impact |  |  |  |  |  | 12 | 2 | 10 |
| Core, non-GAAP measure | $**29169** | $**35413** | $**24576** | $**—** | $**10837** | $**116** | $**2050** | $**8075** |

---

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 | 36 Weeks Ended 9/7/2024 |
| | Cost of sales | Gross profit | Selling, general and administrative expenses | Impairment of intangible assets | Operating profit | Other pension and retiree medical benefits income | Provision for income taxes<sup>(a)</sup> | Net income attributable to noncontrolling interests | Net income attributable to PepsiCo |
| Reported, GAAP measure | $28563 | $35507 | $24846 | $24 | $10637 | $155 | $2045 | $37 | $8055 |
| Items Affecting Comparability |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market net impact | 13 | (13) | (21) |  | 8 |  | 2 |  | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and impairment charges | (16) | 16 | (363) | (14) | 393 | 22 | 90 | 1 | 324 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and divestiture-related charges |  |  | (7) |  | 7 |  | 2 |  | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment and other charges |  |  |  | (10) | 10 |  | 2 |  | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product recall-related impact | (174) | 174 | (7) |  | 181 | 3 | 43 |  | 141 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and retiree medical-related impact |  |  |  |  |  | 17 | 3 |  | 14 |
| Core, non-GAAP measure | $28386 | $35684 | $24448 | $— | $11236 | $197 | $2187 | $38 | $8553 |

---

(a)Provision for income taxes is the expected tax charge/benefit on the underlying item based on the tax laws and income tax rates applicable to the underlying item in its corresponding tax jurisdiction.

(b)Provision for income taxes reflects the unfavorable impact of an income tax audit settlement in our LatAm Foods segment.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **12 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | **36 Weeks Ended** | |
| | **9/6/2025** | | 9/7/2024 | | **Change** | **9/6/2025** | 9/7/2024 | **Change** | |
| Net income attributable to PepsiCo per common share – diluted, GAAP measure | $**1.90** |  | $2.13 |  | **(11)%** | $**4.15** | $5.84 | **(29)%** |  |
| Mark-to-market net impact | **0.01** |  | 0.03 |  |  | **—** |  |  |  |
| Restructuring and impairment charges | **0.08** |  | 0.14 |  |  | **0.34** | 0.24 |  |  |
| Acquisition and divestiture-related charges | **0.12** |  |  |  |  | **0.17** |  |  |  |
| Impairment and other charges | **0.07** |  | 0.01 |  |  | **1.12** | 0.01 |  |  |
| Indirect and income tax impact | **0.09** |  |  |  |  | **0.09** |  |  |  |
| Product recall-related impact | **—** |  |  |  |  | **—** | 0.10 |  |  |
| Pension and retiree medical-related impact | **0.01** |  | 0.01 |  |  | **0.01** | 0.01 |  |  |
| Core net income attributable to PepsiCo per common share – diluted, non-GAAP measure | $**2.29** | <sup>(a)</sup> | $2.31 | <sup>(a)</sup> | **(1)%** | $**5.88** | $6.20 | **(5)%** |  |
| Impact of foreign exchange translation |  |  |  |  | **(1)** |  |  | **2** |  |
| Growth in core net income attributable to PepsiCo per common share – diluted, on a constant currency basis, non-GAAP measure |  |  |  |  | **(2)%** |  |  | **(3.5)%** | <sup>(a)</sup> |

---

(a)Does not sum due to rounding.

**Mark-to-Market Net Impact**

We centrally manage commodity derivatives on behalf of our segments. These commodity derivatives include agricultural, metals, and energy products. Commodity derivatives that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in segment results when the segments recognize the cost of the underlying commodity in operating profit. Therefore, the segments realize the economic effects of the derivative without experiencing any resulting mark-to-market volatility, which remains in corporate unallocated expenses.

**Restructuring and Impairment Charges**

*2019 Multi-Year Productivity Plan*

The 2019 Productivity Plan leverages new technology and business models to further simplify, harmonize and automate processes; re-engineers our go-to-market and information systems, including deploying the

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

right automation for each market; and simplifies our organization and optimizes our manufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan, in 2024, we further expanded and extended the plan through the end of 2030 to take advantage of additional opportunities within the initiatives described above. As a result, we expect to incur pre-tax charges of approximately $6.15 billion, including cash expenditures of approximately $5.1 billion. Plan-to-date through September 6, 2025, we have incurred pre-tax charges of $3.2 billion, including cash expenditures of $2.4 billion. We expect to incur the majority of the remaining pre-tax charges and cash expenditures through 2027, with the balance to be incurred through 2030. Charges include severance and other employee costs, asset impairments and other costs.

See Note 3 to our condensed consolidated financial statements in this Form 10-Q, as well as Note 3 to our consolidated financial statements in our Recast Segment Information, for further information related to our 2019 Productivity Plan.

We regularly evaluate productivity initiatives beyond the productivity plan and other initiatives discussed above and in Note 3 to our condensed consolidated financial statements.

**Acquisition and Divestiture-Related Charges**

Acquisition and divestiture-related charges primarily include transaction expenses, such as consulting, advisory and other professional fees, and merger and integration charges, as well as fair value adjustments to the acquired inventory included in the acquisition-date balance sheets. Merger and integration charges include distribution agreement termination fees, impairment of certain acquisition-related intangibles, employee-related costs, closing costs and other integration costs.

See Note 12 to our condensed consolidated financial statements for further information.

**Impairment and Other Charges**

We recognized charges primarily related to the impairments of the Rockstar and Be & Cheery brands.

See Notes 1 and 4 to our condensed consolidated financial statements for further information.

**Indirect and Income Tax Impact**

We recognized additional expenses related to an indirect and income tax audit settlement in our LatAm Foods segment.

See Note 1 to our condensed consolidated financial statements for further information.

**Product Recall-Related Impact**

We recognized property, plant and equipment write-offs, employee severance costs and other costs in our PFNA segment associated with a previously announced voluntary recall of certain bars and cereals.

See Note 1 to our condensed consolidated financial statements for further information.

**Pension and Retiree Medical-Related Impact**

Pension and retiree medical-related impact includes settlement charges related to lump sum distributions exceeding the total of annual service and interest costs, partially offset by curtailment gains.

See Note 7 to our condensed consolidated financial statements for further information.

**Our Liquidity and Capital Resources**

We believe that our cash generating capability and financial condition, together with our revolving credit facilities, working capital lines and other available methods of debt financing, such as commercial paper borrowings and long-term debt financing, will be adequate to meet our operating, investing and financing

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

needs, including with respect to our net capital spending plans. Our primary sources of liquidity include cash from operations, proceeds obtained from issuances of commercial paper and long-term debt, and cash and cash equivalents. These sources of cash are available to fund cash outflows that have both a short- and long-term component, including debt repayments and related interest payments; payments for acquisitions; operating leases; purchase, marketing, and other contractual commitments, including capital expenditures and the transition tax liability under the TCJ Act. In addition, these sources of cash fund other cash outflows including anticipated dividend payments and share repurchases. We do not have guarantees or off-balance sheet financing arrangements, including variable interest entities, that we believe could have a material impact on our liquidity. See "Our Business Risks" and Note 8 to our condensed consolidated financial statements included in this Form 10-Q, "Item 1A. Risk Factors" in our 2024 Form 10-K and "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks" and Note 8 to our consolidated financial statements included in our Recast Segment Information for further information.

As of September 6, 2025, cash, cash equivalents and short-term investments in our consolidated subsidiaries outside of Russia that are subject to currency controls or currency exchange restrictions were not material. As of September 6, 2025, Russia accounted for 15% of our consolidated cash and cash equivalents. Our sources and uses of cash were not materially adversely impacted by the cash and cash equivalents held in Russia and, to date, we have not identified any material impact on our liquidity or capital resources as a result of these amounts. See "Our Business Risks" for further information on our operations in Russia.

The TCJ Act imposed a one-time mandatory transition tax on undistributed international earnings. As of September 6, 2025, our mandatory transition tax liability was $1.0 billion, which must be paid through 2026 under the provisions of the TCJ Act. See "Our Liquidity and Capital Resources" and Note 5 to our consolidated financial statements included in our Recast Segment Information for further discussion of the TCJ Act.

Supply chain financing arrangements did not have a material impact on our liquidity or capital resources in the periods presented and we do not expect such arrangements to have a material impact on our liquidity or capital resources for the foreseeable future. See Note 13 to our condensed consolidated financial statements for further discussion of supply chain financing arrangements.

***Operating Activities***

During the 36 weeks ended September 6, 2025, net cash provided by operating activities was $5.5 billion, compared to net cash provided by operating activities of $6.2 billion in the prior-year period. The decrease in operating cash flow primarily reflects unfavorable operating profit performance.

***Investing Activities***

During the 36 weeks ended September 6, 2025, net cash used for investing activities was $5.2 billion, primarily reflecting net cash paid in connection with our acquisitions of poppi of $1.9 billion and Siete of $1.2 billion, as well as net capital spending of $2.2 billion.

We regularly review our plans with respect to net capital spending and believe that we have sufficient liquidity to meet our net capital spending needs.

***Financing Activities***

During the 36 weeks ended September 6, 2025, net cash used for financing activities was $1.0 billion, primarily reflecting the return of operating cash flow to our shareholders through dividend payments and share repurchases of $6.4 billion and payments of long-term debt borrowings of $3.2 billion, partially offset by proceeds from the issuances of long-term debt of $8.2 billion.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

We annually review our capital structure with our Board of Directors, including our dividend policy and share repurchase activity. On February 10, 2022, we announced a share repurchase program providing for the repurchase of up to $10.0 billion of PepsiCo common stock which commenced on February 11, 2022 and will expire on February 28, 2026. In addition, on February 4, 2025, we announced a 5% increase in our annualized dividend to $5.69 per share from $5.42 per share, effective with the dividend paid in June 2025. We expect to return a total of approximately $8.6 billion to shareholders in 2025, comprising dividends of approximately $7.6 billion and share repurchases of approximately $1.0 billion.

***Free Cash Flow***

The table below reconciles net cash provided by operating activities, as reflected on our cash flow statement, to our free cash flow. Free cash flow is a non-GAAP financial measure. For further information on free cash flow, see "Non-GAAP Measures."

---

| | | |
|:---|:---|:---|
| | **36 Weeks Ended** | **36 Weeks Ended** |
| | **9/6/2025** | 9/7/2024 |
| Net cash provided by operating activities, GAAP measure | $**5468** | $6220 |
| &nbsp;&nbsp;&nbsp;Capital spending | **(2499)** | (2850) |
| &nbsp;&nbsp;&nbsp;Sales of property, plant and equipment | **272** | 177 |
| Free cash flow, non-GAAP measure | $**3241** | $3547 |

---

We use free cash flow primarily for acquisitions and financing activities, including debt repayments, dividends and share repurchases. We expect to continue to return free cash flow to our shareholders primarily through dividends while maintaining Tier 1 commercial paper access, which we believe will facilitate appropriate financial flexibility and ready access to global capital and credit markets at favorable interest rates. See "Our Business Risks" included in this Form 10-Q, "Item 1A. Risk Factors" in our 2024 Form 10-K and "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks," included in our Recast Segment Information, for certain factors that may impact our credit ratings or our operating cash flows.

Any downgrade of our credit ratings by a credit rating agency, especially any downgrade to below investment grade, whether or not as a result of our actions or factors which are beyond our control, could increase our future borrowing costs and impair our ability to access capital and credit markets on terms commercially acceptable to us, or at all. In addition, any downgrade of our current short-term credit ratings could impair our ability to access the commercial paper market with the same flexibility that we have experienced historically, and therefore require us to rely more heavily on more expensive types of debt financing. See Note 8 to our condensed consolidated financial statements and "Our Business Risks" included in this Form 10-Q, as well as "Item 1A. Risk Factors" in our 2024 Form 10-K and "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks" included in our Recast Segment Information for further information.

**Changes in Line Items in Our Condensed Consolidated Financial Statements**

Changes in line items in the income statement are discussed in "Results of Operations – Consolidated Review," "Results of Operations – Segment Review" and "Items Affecting Comparability."

Changes in line items in the cash flow statement are discussed in "Our Liquidity and Capital Resources."

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

Changes in line items in the balance sheet are discussed below:

***Total Assets***

Total assets were $106.6 billion as of September 6, 2025, compared to $99.5 billion as of December 28, 2024. Assets were impacted primarily by the following line items:

---

| | |
|:---|:---|
| | **Change** <sup>(a)</sup>  |
| Accounts and notes receivable, less allowance <sup>(b)</sup> | $2.3 |
| Property, Plant and Equipment, net <sup>(c)</sup> | $1.0 |
| Goodwill <sup>(d)</sup> | $1.3 |
| Other Assets <sup>(e)</sup> | $1.7 |

---

***Total Liabilities***

As of September 6, 2025, total liabilities were $87.0 billion, compared to $81.3 billion as of December 28, 2024. Liabilities were impacted primarily by the following line items:

---

| | |
|:---|:---|
| | **Change** <sup>(a)</sup>  |
| Long-term debt obligations <sup>(f)</sup> | $6.9 |
| Other liabilities <sup>(g)</sup> | $(1.1) |

---

(a)Increase/(decrease) in billions.

(b)Primarily reflects improved operating performance coupled with appreciation of certain currencies.

(c)Primarily reflects the appreciation of the Russian ruble, Mexican peso and the euro.

(d)See Notes 4 and 12 to our condensed consolidated financial statements for further information.

(e)See Note 9 to our condensed consolidated financial statements for further information.

(f)See Note 8 to our condensed consolidated financial statements for further information.

(g)Primarily reflects a reclass of the transition tax liability to current.

***Total Equity***

See the equity statement and Notes 9 and 11 to our condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**Report of Independent Registered Public Accounting Firm**

To the Shareholders and Board of Directors

PepsiCo, Inc.:

*Results of Review of Interim Financial Information* 

We have reviewed the Condensed Consolidated Balance Sheet of PepsiCo, Inc. and subsidiaries (the Company) as of September 6, 2025, the related Condensed Consolidated Statements of Income, Comprehensive Income, and Equity for the twelve and thirty-six weeks ended September 6, 2025 and September 7, 2024, the related Condensed Consolidated Statement of Cash Flows for the thirty-six weeks ended September 6, 2025 and September 7, 2024, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Consolidated Balance Sheet of the Company as of December 28, 2024, and the related Consolidated Statements of Income, Comprehensive Income, Cash Flows and Equity for the fiscal year then ended (not presented herein); and in our report dated February 3, 2025, except for the change in the composition of reportable segments and the related impacts discussed in Notes 1, 3, 4, 9, and 13, as to which the date is July 16, 2025, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying Condensed Consolidated Balance Sheet as of December 28, 2024 is fairly stated, in all material respects, in relation to the Consolidated Balance Sheet from which it has been derived.

*Basis for Review Results*

This consolidated interim financial information is the responsibility of the Company's management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ KPMG LLP

New York, New York

October 8, 2025

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**ITEM 3. Quantitative and Qualitative Disclosures About Market Risk.**

See "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks." In addition, see "Item 1A. Risk Factors" in our 2024 Form 10-K and "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks" and Note 9 to our consolidated financial statements in our Recast Segment Information.

**ITEM 4. Controls and Procedures.** 

As of the end of the period covered by this report, we carried out an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this report our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

During the 12 weeks ended September 6, 2025, we continued migrating certain of our financial processing systems to an Enterprise Resource Planning (ERP) system. These systems implementations are part of our ongoing global business transformation initiative, and we plan to continue implementing such systems throughout other parts of our businesses in phases over the next several years. In connection with these ERP implementations, we are updating and will continue to update our internal control over financial reporting, as necessary, to accommodate modifications to our business processes and accounting procedures. During the 12 weeks ended September 6, 2025, we continued implementing these systems, resulting in changes that materially affected our internal control over financial reporting. These system implementations did not have an adverse effect, nor do we expect will have an adverse effect, on our internal control over financial reporting. In addition, in connection with our 2019 multi-year productivity plan, we continue to migrate to shared business models across our operations to further simplify, harmonize and automate processes. In connection with this multi-year productivity plan and resulting business process changes, we continue to enhance the design and documentation of our internal control over financial reporting processes to maintain effective controls over our financial reporting. These business process changes have not materially affected, and we do not expect them to materially affect, our internal control over financial reporting.

Except with respect to the continued implementation of ERP systems, there have been no changes in our internal control over financial reporting during the 12 weeks ended September 6, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We will continue to assess the impact on our internal control over financial reporting as we continue to implement our ERP solution and our 2019 multi-year productivity plan.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**PART II OTHER INFORMATION**

**ITEM 1. Legal Proceedings.**

The following information should be read in conjunction with the discussion set forth under Part I, "Item 3. Legal Proceedings" in our 2024 Form 10-K and Part II, "Item 1. Legal Proceedings" in our Quarterly Report on Form 10-Q for the quarter ended March 22, 2025 and our Quarterly Report on Form 10-Q for the quarter ended June 14, 2025 (Q2 2025 Form 10-Q).

As previously disclosed, on June 20, 2024, the Mayor and City Council of Baltimore, Maryland filed a lawsuit against PepsiCo, Inc., Frito-Lay, Inc., Frito-Lay North America, Inc., and several other unrelated parties asserting claims for public nuisance, deceptive acts or practices in the conduct of business, and other related claims based on allegations that the defendants' conduct allegedly resulted in plastic pollution in Baltimore (the Baltimore Matter). On July 21, 2025, the Circuit Court for Baltimore City, Maryland dismissed with prejudice all claims except for public nuisance. The court did not opine on the public nuisance claim and stayed the case pending a decision in three cases unrelated to PepsiCo that are before the Maryland Supreme Court. Please refer to Part I, "Item 3. Legal Proceedings" in our 2024 Form 10-K for additional information.

In addition, we and our subsidiaries are party to a variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations. While the results of the NYS Matter and Los Angeles Matters (each, as defined in our 2024 Form 10-K), the Baltimore Matter, the USVI Matter (as defined in the Q2 2025 Form 10-Q) and each such other litigation, claim, legal or regulatory proceeding, inquiry and investigation cannot be predicted with certainty, management believes that the final outcome of the foregoing is not expected to have a material adverse effect on our financial condition, results of operations or cash flows. See also "Item 1. Business – Regulatory Matters" and "Item 1A. Risk Factors" in our 2024 Form 10-K.

**ITEM 1A. Risk Factors.**

There have been no material changes with respect to the risk factors disclosed in our 2024 Form 10-K.

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

A summary of our common stock repurchases (in millions, except average price per share) during the 12 weeks ended September 6, 2025 is set forth in the table below.

**Issuer Purchases of Common Stock** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total**<br>**Number of**<br>**Shares**<br>**Repurchased**<sup>(a)</sup> | **Average Price<br>Paid Per Share** | **Total Number<br>of Shares<br>Purchased as<br>Part of Publicly<br>Announced<br>Plans or<br>Programs** | **Approximate<br>Dollar Value of<br>Shares That May Yet Be<br>Purchased<br>Under the Plans<br>or Programs** |
| 6/14/2025 |  |  |  | $6003 |
| 6/15/2025 - 7/12/2025 | 0.7 | $131.62 | 0.7 | (93) |
|  |  |  |  | 5910 |
| 7/13/2025 - 8/9/2025 | 0.5 | $140.01 | 0.5 | (74) |
|  |  |  |  | 5836 |
| 8/10/2025 - 9/6/2025 | 0.7 | $148.35 | 0.7 | (96) |
| **Total** | **1.9** | $**139.75** | **1.9** | $**5740** |

---

(a)All shares were repurchased in open market transactions pursuant to the $10 billion repurchase program authorized by our Board and publicly announced on February 10, 2022, which commenced on February 11, 2022 and will expire on February 28, 2026. Shares repurchased under this program may be repurchased in open market transactions, in privately negotiated transactions, in accelerated stock repurchase transactions or otherwise.

**ITEM 5. Other Information.**

During the 12 weeks ended September 6, 2025, none of our directors or executive officers adopted, modified or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement" as such terms are defined under Item 408 of Regulation S-K.

**ITEM 6. Exhibits.**

See "Index to Exhibits" on page <u>[55](#i24b2960c8bf94fd09c758d4af3964e6e_280)</u>.<br>

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**<u>INDEX TO EXHIBITS</u>**

**<u>ITEM 6</u>**

---

| | |
|:---|:---|
| **<u>EXHIBIT</u>** | |
| <u>[Exhibit 3.1](https://www.sec.gov/Archives/edgar/data/77476/000007747619000046/exhibit31articlesofinc.htm)</u> | <u>[Amended and Restated Articles of Incorporation of PepsiCo, Inc., effective as of May 1, 2019, which are incorporated herein by reference to Exhibit 3.1 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 3, 2019.](https://www.sec.gov/Archives/edgar/data/77476/000007747619000046/exhibit31articlesofinc.htm)</u> |
| <u>[Exhibit 3.2](https://www.sec.gov/Archives/edgar/data/77476/000007747624000046/pepsico-ex32xseptember2020.htm)</u> | <u>[By-Laws of PepsiCo, Inc., as amended and restated, effective as of September 20, 2024, which are incorporated herein by reference to Exhibit 3.2 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 20, 2024.](https://www.sec.gov/Archives/edgar/data/77476/000007747624000046/pepsico-ex32xseptember2020.htm)</u> |
| <u>[Exhibit 4.1](https://www.sec.gov/Archives/edgar/data/77476/000110465925070029/tm2516509d5_ex4-1.htm)</u> | <u>[Form of 4.100% Senior Note due 2029, which is incorporated herein by reference to Exhibit 4.1 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 23, 2025.](https://www.sec.gov/Archives/edgar/data/77476/000110465925070029/tm2516509d5_ex4-1.htm)</u> |
| <u>[Exhibit 4.2](https://www.sec.gov/Archives/edgar/data/77476/000110465925070029/tm2516509d5_ex4-2.htm)</u> | <u>[Form of 4.300% Senior Note due 2030, which is incorporated herein by reference to Exhibit 4.2 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 23, 2025.](https://www.sec.gov/Archives/edgar/data/77476/000110465925070029/tm2516509d5_ex4-2.htm)</u> |
| <u>[Exhibit 4.3](https://www.sec.gov/Archives/edgar/data/77476/000110465925070029/tm2516509d5_ex4-3.htm)</u> | <u>[Form of 4.650% Senior Note due 2032, which is incorporated herein by reference to Exhibit 4.3 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 23, 2025.](https://www.sec.gov/Archives/edgar/data/77476/000110465925070029/tm2516509d5_ex4-3.htm)</u> |
| <u>[Exhibit 4.4](https://www.sec.gov/Archives/edgar/data/77476/000110465925070029/tm2516509d5_ex4-4.htm)</u> | <u>[Form of 5.000% Senior Note due 2035, which is incorporated herein by reference to Exhibit 4.4 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 23, 2025.](https://www.sec.gov/Archives/edgar/data/77476/000110465925070029/tm2516509d5_ex4-4.htm)</u> |
| <u>[Exhibit 4.5](https://www.sec.gov/Archives/edgar/data/77476/000110465925071182/tm2516509d4_ex4-1.htm)</u> | <u>[Form of 3.450% Senior Note due 2037, which is incorporated herein by reference to Exhibit 4.1 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 28, 2025.](https://www.sec.gov/Archives/edgar/data/77476/000110465925071182/tm2516509d4_ex4-1.htm)</u> |
| <u>[Exhibit 4.6](https://www.sec.gov/Archives/edgar/data/77476/000110465925071182/tm2516509d4_ex4-2.htm)</u> | <u>[Form of 4.050% Senior Note due 2055, which is incorporated herein by reference to Exhibit 4.2 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 28, 2025.](https://www.sec.gov/Archives/edgar/data/77476/000110465925071182/tm2516509d4_ex4-2.htm)</u> |
| <u>[Exhibit 15](exhibit15-q32025.htm)</u> | <u>[Letter re: Unaudited Interim Financial Information.](exhibit15-q32025.htm)</u> |
| <u>[Exhibit 22](exhibit22-q32025.htm)</u> | <u>[Subsidiary Issuer of Guaranteed Securities.](exhibit22-q32025.htm)</u> |
| <u>[Exhibit 31](exhibit31-q32025.htm)</u> | <u>[Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit31-q32025.htm)</u> |
| <u>[Exhibit 32](exhibit32-q32025.htm)</u> | <u>[Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit32-q32025.htm)</u> |
| Exhibit 101 | The following materials from PepsiCo, Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 6, 2025 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statement of Income, (ii) the Condensed Consolidated Statement of Comprehensive Income, (iii) the Condensed Consolidated Statement of Cash Flows, (iv) the Condensed Consolidated Balance Sheet, (v) the Condensed Consolidated Statement of Equity, and (vi) Notes to the Condensed Consolidated Financial Statements. |
| Exhibit 104 | The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended September 6, 2025, formatted in iXBRL and contained in Exhibit 101. |

---

------

<u>[**Table of Contents**](#i24b2960c8bf94fd09c758d4af3964e6e_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;PepsiCo, Inc.&nbsp;&nbsp;&nbsp;&nbsp;</u> |
| | | (Registrant) |
| Date: | <u>October 8, 2025</u> | /s/ Christine E. Tammara |
|  |  | Christine E. Tammara |
|  |  | Senior Vice President and Controller |
|  |  | (Principal Accounting Officer) |
| Date: | <u>October 8, 2025</u> | /s/ David Flavell |
|  |  | David Flavell |
|  |  | Executive Vice President, General Counsel and Corporate Secretary |
|  |  | (Duly Authorized Officer) |

---

## Ex-15

**EXHIBIT 15**

**Accountant's Acknowledgement**

To the Shareholders and Board of Directors

PepsiCo, Inc.:

We hereby acknowledge our awareness of the use of our report dated October 8, 2025 included within the Quarterly Report on Form 10-Q of PepsiCo, Inc. for the twelve and thirty-six weeks ended September 6, 2025, and incorporated by reference in the following Registration Statements and in the related Prospectuses:

**<u>Description, Registration Statement Number</u>**

*<u>Form S-3</u>*

• PepsiCo Automatic Shelf Registration Statement, 333-277003

• PepsiCo Automatic Shelf Registration Statement, 333-266332

• PepsiAmericas, Inc. 2000 Stock Incentive Plan, 333-165176

• PBG 2004 Long Term Incentive Plan, PBG 2002 Long Term Incentive Plan, PBG Long Term Incentive Plan, The Pepsi Bottling Group, Inc. 1999 Long Term Incentive Plan and PBG Stock Incentive Plan, 333-165177

*<u>Form S-8</u>*

• The PepsiCo Savings Plan, 333-76204, 333-76196, 333-150867 and 333-150868

• PepsiCo, Inc. 2007 Long-Term Incentive Plan, 333-142811, 333-166740 and 333-279335

• PepsiCo, Inc. 2003 Long-Term Incentive Plan, 333-109509

• PepsiCo SharePower Stock Option Plan, 33-29037, 33-35602, 33-42058, 33-51496, 33-54731, 33-66150 and 333-109513

• Director Stock Plan, 33-22970 and 333-110030

• 1979 Incentive Plan and the 1987 Incentive Plan, 33-19539

• 1994 Long-Term Incentive Plan, 33-54733

• PepsiCo, Inc. 1995 Stock Option Incentive Plan, 33-61731, 333-09363 and 333-109514

• 1979 Incentive Plan, 2-65410

• PepsiCo, Inc. Long Term Savings Program, 2-82645, 33-51514 and 33-60965

• PepsiCo 401(k) Plan, 333-89265

• Retirement Savings and Investment Plan for Union Employees of Tropicana Products, Inc. and Affiliates (Teamster Local Union #173) and the Retirement Savings and Investment Plan for Union Employees of Tropicana Products, Inc. and Affiliates, 333-65992

• The Quaker Long Term Incentive Plan of 1990, The Quaker Long Term Incentive Plan of 1999 and The Quaker Oats Company Stock Option Plan for Outside Directors, 333-66632

• The Quaker 401(k) Plan for Salaried Employees and The Quaker 401(k) Plan for Hourly Employees, 333-66634

• The PepsiCo Share Award Plan, 333-87526

• PBG 401(k) Savings Program, PBG 401(k) Program, PepsiAmericas, Inc. Salaried 401(k) Plan and PepsiAmericas, Inc. Hourly 401(k) Plan, 333-165106

• PBG 2004 Long Term Incentive Plan, PBG 2002 Long Term Incentive Plan, PBG Long Term Incentive Plan, The Pepsi Bottling Group, Inc. 1999 Long Term Incentive Plan, PBG Directors' Stock Plan, PBG Stock Incentive Plan and PepsiAmericas, Inc. 2000 Stock Incentive Plan, 333-165107

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/ KPMG LLP

New York, New York

October 8, 2025

## Ex-22

**Exhibit 22**

**Subsidiary Issuer of Guaranteed Securities**

As of September 6, 2025, PepsiCo, Inc. fully and unconditionally guaranteed on a senior unsecured basis the following unsecured registered notes issued by PepsiCo Singapore Financing I Pte. Ltd., PepsiCo Inc.'s wholly-owned consolidated finance subsidiary incorporated as a private company limited by shares in the Republic of Singapore:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Floating Rate Notes due 2027

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4.650% Senior Notes due 2027

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.550% Senior Notes due 2029

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4.700% Senior Notes due 2034

## Ex-31

**EXHIBIT 31** 

**CERTIFICATION** 

I, **Ramon L. Laguarta,** certify that:

1. I have reviewed this quarterly report on Form 10-Q of PepsiCo, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: October 8, 2025 | /s/ Ramon L. Laguarta |
| | Ramon L. Laguarta |
| | Chairman of the Board of Directors and |
| | Chief Executive Officer |

---

------

**CERTIFICATION** 

I, **James T. Caulfield,** certify that:

1. I have reviewed this quarterly report on Form 10-Q of PepsiCo, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: October 8, 2025 | /s/ James T. Caulfield |
| | James T. Caulfield |
| | Chief Financial Officer |

---

## Ex-32

**EXHIBIT 32**

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PepsiCo, Inc. (the "Corporation") on Form 10-Q for the quarterly period ended September 6, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ramon L. Laguarta, Chairman of the Board of Directors and Chief Executive Officer of the Corporation, certify to my knowledge, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that:

&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

---

| | |
|:---|:---|
| Date: October 8, 2025 | /s/ Ramon L. Laguarta |
| | Ramon L. Laguarta |
| | Chairman of the Board of Directors and |
| | Chief Executive Officer |

---

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PepsiCo, Inc. (the "Corporation") on Form 10-Q for the quarterly period ended September 6, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, James T. Caulfield, Chief Financial Officer of the Corporation, certify to my knowledge, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

---

| | |
|:---|:---|
| Date: October 8, 2025 | /s/ James T. Caulfield |
| | James T. Caulfield |
| | Chief Financial Officer |

---

<br>